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EXPLANATION OF DISSERTATION FORMAT 
This dissertation is presented in the alternate format, as outlined in 
the Iowa State University Graduate College Thesis Manual. Use of the 
alternate format allows preparation of independent sections which is in a 
form suitable for submission to a scientific journal for publication. 
Following the Introduction on Page 2, a Literature Review of topics 
pertinent to the dissertation research is presented. Following the 
Literature Review are two papers that have been prepared from research 
performed to partially fulfill requirements for the Ph.D. degree. Each 
paper is complete in itself and includes abstract, introduction, materials 
and methods, results, discussion, and references sections. The term 
"cholecalciferol" has been used in place of "vitamin Dj" in the two 
research papers to conform to journal specifications. A general summary 
follows the papers and is intended to cite briefly the major conclusions 
of the dissertation research. 
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INTRODUCTION 
Coronary heart disease (CHD) accounts for more deaths annually in the 
United States than does any other disease or group of diseases. More than 
1.25 million heart attacks occur each year and more than 500,000 people 
die as a result (National Heart, Lung and Blood Institute, 1984). 
Morbidity and mortality from CHD cost the United States an estimated $49 
billion in 1985 in direct health care expenditures and lost productivity 
(Surgeon General's Report on Nutrition and Health, 1988). The established 
risk factors for atherosclerosis are age, sex, hypertension, cigarette 
smoking, diabetes and hypercholesterolemia. Diet is believed to play a 
major role in the development of atherosclerosis, primarily because of the 
positive correlation between certain dietary components and 
hypercholesterolemia. 
Calcium and vitamin D are integral components of the American diet. 
Numerous epidemiological and nutritional studies have shown that dietary 
calcium and vitamin D can affect the concentration of plasma cholesterol 
and the development of atherosclerosis. Dietary calcium, when given above 
daily requirements, decreased the concentration of plasma cholesterol in 
humans (Yacowitz et al., 1965; Carlson et al., 1971; Bierenbaum et al., 
1972), rabbits (Yacowitz et al., 1971; Renaud et al., 1983) and goats 
(Hines et al., 1985). Dietary calcium has been purported to have a 
protective role in atherosclerosis (Yacowitz et al., 1971; Renaud et al., 
1983). In contrast, calcification is a characteristic of atherosclerotic 
plaques (Moon, 1972). Phair (1988) suggested that intracellular calcium 
is the pathological second messenger of atherogenesis and that diverse 
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risk factors for the development of atherosclerosis promote intracellular 
calcium accumulation. 
Vitamin D has been incriminated as a positive risk factor in 
atherosclerosis, but reports on the role of vitamin D in the development 
of hypercholesterolemia are not conclusive. Excess dietary vitamin D has 
been shown to be hypercholesterolemic in humans (Fleischman et al., 1970; 
Curcic and Curcic, 1975), squirrel monkeys (Peng et al., 1978), rats 
(Fleischman et al., 1972) and swine (Huang et al., 1977). In contrast, 
excess dietary vitamin D did not cause hypercholesterolemia in studies 
with humans (Carlson et al., 1970; Vik et al,, 1979), rats (Jurgens et 
al,, 1971) and goats (Mines et al., 1985). Excess vitamin D induced or 
increased atherosclerotic lesions in rats (Gambal and Murphy, 1979), 
rabbits (Mass et al., 1969), squirrel monkeys (Peng et al., 1978) and 
swine (Huang et al., 1977; Toda et al., 1985). Peng and Taylor (1980) 
concluded that long-term consumption of excess vitamin D may be a major 
cause of atherosclerosis, with cholesterol intake and serum cholesterol 
concentrations playing an important secondary role. 
Studies in humans often are difficult or impossible because of 
individual variation in response, lack of compliance to experimental 
diets, and nonacceptability in use of radioactive compounds and of 
surgical and sampling procedures. The domestic pig is a useful model for 
studies of human physiology (Tumbleson, 1986; Miller and Ullrey, 1987). 
Littermate groups of pigs that have a similar genetic background can be 
used to decrease variation in individual response to treatments. Pigs are 
omnivores and will consume diets resembling human diets (Diersen-Schade et 
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al., 1985). The pig is adaptable to surgical and sampling procedures 
(Sambrook, 1981; Swindle, 1983; Thurmon et al., 1987). 
The primary route of excretion of cholesterol from the body is through 
conversion to bile acids and biliary cholesterol. The hypothesis of this 
study is that the amounts of dietary calcium and vitamin Dj influence the 
entry rate of cholesterol of plasma low-density lipoproteins (LDL) into 
tissues and into bile as bile acids and biliary cholesterol. The specific 
objectives of this study are to determine the effects of amount of dietary 
calcium and vitamin Dj fed to young swine on: (1) concentrations of 
cholesterol in aorta, heart, liver, muscle and viscera of pigs, (2) uptake 
of LDL from plasma by liver and subsequent transfer of the LDL-cholesterol 
into bile as cholesterol, (3) conversion of LDL-cholesterol to bile acids 
in liver and the secretion of the bile acids into the bile and (4) bile 
flow and composition. 
REVIEW OF LITERATURE 
Atherosclerosis 
The lesions of atherosclerosis have been observed in humans for 
centuries. The generic term "arteriosclerosis" for scarring and 
calcification of arteries was coined by Lobstein in 1829, and the 
distinctive type of arteriosclerosis characterized by lipid-rich deposits 
was named "atherosclerosis" by Marchand in 1904 (McGill, 1988). Herrick 
(1912) linked the clinical signs and symptoms of myocardial infarction 
with atherosclerosis and thrombosis of the coronary arteries. 
Although much is known about the natural history of atherosclerotic 
lesions, the atherogenic process is not a precise series of events from a 
single, specific initiating factor to the resulting clinical consequences. 
Atherogenesis begins in early childhood with the formation of the fatty 
streak, the earliest lesion of atherosclerosis (Holman et al., 1958; 
McGill, 1968a). Fatty streaks are grossly flat, lipid-rich lesions 
consisting of macrophages and some smooth muscle cells (McGill, 1968b). 
The lipid deposits are predominantly cholesterol and cholesteryl esters 
(Cornwell et al., 1975), By the time the child reaches the age of ten 
years, fatty streaks cover approximately 10% of the aortic intimai 
surface; this coverage increases to 30-50% by the age of 25 years (McGill, 
1968a). 
The relationship of fatty streaks to the next lesion in the 
progression of atherosclerosis, the fibrous plaque, is controversial 
(McGill, 1984). Not all fatty streaks progress to fibrous plaques, but 
fibrous plaques may occur at anatomical sites that previously contained 
6 
fatty streaks. Faggiotto and Ross (1984) showed in a 
hypercholesterolemic, nonhuman primate model that fatty streaks were the 
earliest lesions to develop and that many of the advanced lesions of 
atherosclerosis occurred at sites where fatty streaks were originally 
present. In summary, it seems that fatty streaks are of widespread 
occurrence, and most remain harmless. In certain locations, and 
especially in predisposed individuals, these streaks may evolve into 
fibrous plaques. 
Regardless of the pre-existing condition of the site, fibrous plaques 
begin to appear in arteries after approximately age 20 (Strong et al., 
1978). The fibrous plaque is a rounded, raised, whitish lesion, 
approximately 1 centimeter in diameter. It consists of a fibrous cap of 
smooth muscle cells in a matrix of elastin, collagen, and proteoglycans 
(Ross et al., 1984). Beneath the fibrous cap, the lesions are highly 
cellular and contain a mixture of macrophages and smooth muscle cells, 
some of which have incorporated lipid and become transformed into foam 
cells (Gaton and Wolman, 1977). Under the cell-rich region there may be 
an area of necrotic debris^ extracellular lipid droplets, cholesterol 
crystals, and calcium deposits (Moon, 1972). Also, proliferating small 
blood vessels from the adventitia may be observed (Munro and Cotran, 
1988). 
After the person reaches the age of 30, fibrous plaques are the 
predominant type of lesion, and lesion complications may begin to occur. 
Clinical disease in the form of myocardial infarction, stroke, aortic 
aneurysm, and gangrene of extremities may occur after the age of 40 
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(McGill, 1984). The most ominous complication is continued growth of the 
fibrous plaque until it produces stenosis of the arterial lumen, 
ulceration of the fibrous cap, or hemorrhage into the plaque from the 
small vessels that have grown into it. Ulceration or hemorrhage, in turn, 
predisposes to the most serious complication, thrombosis, which rapidly 
occludes the artery, thereby producing infarction of the tissue supplied 
by that artery. 
Several theories have been proposed to describe the initiation of 
atherogenesis. One group of theories held that atherosclerosis is an 
infiltration of blood-borne lipid into the arterial wall (Steinberg, 
1987). Lipid infiltration alone, however, does not explain the cellular 
proliferation observed in atherosclerotic lesions. Ross and Glomset 
(1976) proposed the "response to injury" hypothesis, which was based on 
two important experimental observations: (1) that smooth muscle cell 
proliferation and atherosclerotic plaques can be induced by endothelial 
denudation, and (2) that a factor derived from platelets can induce smooth 
muscle growth in vitro. Ross (1986) updated the response-to-injury 
hypothesis in four ways: (1) the endothelium can respond to a variety of 
stimuli, indicating that non-denuding injury may be as important in 
initiating atherosclerosis as denudation, (2) platelets are not the sole 
initiators of smooth muscle cell proliferation, (3) monocytes and 
macrophages are major components of lesions and play a role in initiation 
and progression, and (4) several pathways may lead from arterial injury to 
the formation of advanced lesions. 
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Currently, the role of monocytes and macrophages in atherogenesis is 
receiving great attention. Recent advances have been made toward 
understanding the development and functions of these cells (Nathan et al., 
1980). Blood monocytes can enter tissues and become tissue macrophages in 
response to chemotactic signals. The recruitment of circulating monocytes 
through the arterial endothelium and into the intima has been reported in 
rats (Joris et al., 1983), rabbits (Watanabe et al., 1985), pigeons (Lewis 
et al., 1982), pigs (Gerrity, 1981), baboons (Schwartz et al., 1980), pig-
tailed macaques (Faggiotto et al., 1984), rhesus monkeys (Stary, 1974), 
and man (Geer et al., 1961). Subendothelial migration and localization of 
these monocytes are the earliest events in fatty streak formation and thus 
in atherogenesis (Ross, 1986). Arterial macrophages distend with 
accumulated lipid to become foam cells (Gerrity, 1981; Clarkson et al., 
1987). Macrophages accumulate lipid by ingesting and degrading 
lipoproteins that have leaked through the endothelium, taking up modified 
LDL by the acetyl-LDL or "scavenger" receptor, or by phagocytizing whole 
cells (Brown and Goldstein, 1983a). The scavenger receptor does not seem 
to be down-regulated as are receptors for native LDL (Goldstein et al., 
1979; Fogelman et al., 1980). 
The secretory products of macrophages have particular relevance to 
atherosclerosis (Nathan, 1987). Interleukin 1 and tumor necrosis factor, 
both produced by macrophages, are capable of inducing monocyte adhesion to 
endothelial cells (Bevilacqua et al., 1985). Leukotriene B^, complement 
fragment C5a, transforming growth factor-B, interleukin 1, tumor necrosis 
factor, granulocyte-macrophage colony stimulating factor, and platelet-
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derived growth factor are examples of macrophage products that are 
chemotactic for monocytes (Munro and Cotran, 1988). These two activities, 
inducing increased endothelial adhesiveness and monocyte chemotaxis, may 
form an amplification mechanism for further recruitment of monocytes into 
the atheromatous plaque. Chemoattractants and growth factors from 
macrophages also cause migration and proliferation of smooth muscle cells 
(Greenburg and Hunt, 1978). Extensive mechanical stretching caused by 
increased number and size of macrophages and smooth muscle cells, in 
addition to the cytotoxic substances and proteolytic enzymes produced by 
the macrophages (Nathan, 1987), may participate in the tissue destruction 
and plaque ulceration seen in advanced atherosclerotic lesions. 
Whereas macrophages are the major constituent of fatty streaks, smooth 
muscle cells are the predominant type of cell in fibrous plaques (Ross, 
1986). Smooth muscle cells, like monocytes, can respond to a number of 
chemotactic factors. Clowes and Schwartz (1985) observed that in an 
artery injured by balloon endothelial denudation, the source of intimai 
smooth muscle cells is the media. There is early replication of smooth 
muscle cells within the media, followed by migration into the intima and 
further replication. 
A phenotypic change occurs when smooth muscle cells move into the 
intima. Two different phenotypic states have been described for smooth 
muscle cells, the "synthetic" and "contractile" states (Chamley-Campbell 
et al., 1981; Thyberg et al., 1983). In young animals, smooth muscle 
cells are in the synthetic state; proliferation and secretion of 
connective tissue proteins, such as collagen and elastin, occurs (Ross and 
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Klebanoff, 1971). Smooth muscle cells in adult animals are normally in 
the contractile state, characterized by a cytoplasm filled with actin, 
myosin, and tropomyosin filaments (Gerrity and Cliff, 1975). A shift from 
the contractile to the synthetic state can be induced by injury to the 
aorta (Chamley-Campbell, 1981). Huang et al. (1977) observed that smooth 
muscle cells in aortas of atherosclerotic swine had characteristics 
similar to synthetic-state cells described by Gerrity and Cliff (1975). 
Kim et al. (1987) reported that in hyperlipidemic swine 90% of intimai 
smooth muscle cells are in the synthetic state, but in normolipidemic 
swine only 10% of the intimai smooth muscle cells are in the synthetic 
state. Smooth muscle cells in the synthetic state in atheromatous lesions 
can produce an enormous amount of connective-tissue matrix that 
contributes to the manifestation of the clinical symptoms of 
atherosclerosis (Burke and Ross, 1979). Smooth muscle cells also have 
receptors for LDL and can accumulate lipid to the point of becoming foam 
cells. 
Ross (1986) outlined several pathways in the progression from 
endothelial injury or monocyte adhesion to the occlusive damage caused by 
advanced lesions. Recent reports indicate that atherosclerotic lesions 
can be arrested (McGill, 1984) and some even regress (Faggiotto and Ross, 
1984; Haust, 1983). Two ways that regression may occur are by decreasing 
the concentration of LDL-cholesterol in blood and/or by increasing the HDL 
concentration, the so-called "reverse cholesterol transport" hypothesis. 
These will by discussed in the section on cholesterol metabolism. 
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Atherosclerosis arises from a complex interaction of environmental 
factors with genetic factors. A heritability of 0.63 for coronary artery 
disease of early onset in family studies has been reported by Nora et al. 
(1980). Use of recombinant DNA techniques has identified the chromosomal 
locations of all the major apolipoprotein genes and permitted the detailed 
study of their genomic structure. The apolipoproteins are dispersed among 
four chromosomes, numbers 1, 2, 11, and 19 (Breslow, 1985; Luo et al., 
1986). Galton (1987) reviewed studies that identified the major alleles 
that segregate with the inheritance of premature coronary artery disease. 
Identification of these "atherogenes" may allow prediction from an early 
age of individuals who are predisposed to develop premature 
atherosclerosis. Modification of environmental factors then could be 
instituted to decrease the future risk of death or disability from the 
resulting arterial stenosis. 
Cholesterol Metabolism 
The two sources of cholesterol in the body pool of man are dietary 
absorption (300-500 mg/day) and endogenous synthesis (700-900 mg/day) 
(Turley and Dietschy, 1982). Synthesis of cholesterol can occur in 
virtually every mammalian cell, with the possible exception of mature red 
blood cells (Sabine, 1977). In humans and many species of animals, the 
liver and intestine are the most important organs for the synthesis of 
cholesterol (Dietschy and Wilson, 1970). Adipose tissue is of minor 
importance in most animals, but can be a major contributor to total 
cholesterol synthesis in obese humans (Angel and Bray, 1979). In guinea 
pigs and rabbits, two species frequently used in cholesterol research. 
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skin and carcass account for greater sterol synthesis than do liver and 
intestine (Spady and Dietschy, 1983). In swine, liver, intestine, and 
adipose tissues are the major sites of cholesterol synthesis (Huang and 
Kummerow, 1966), 
The complex pathway of cholesterol synthesis from acetyl-coenzyme A 
(acetyl-CoA) to the 27-carbon molecule is outlined in most biochemistry 
textbooks (e.g., Stryer, 1988). Glucose is the most common source of 
acetyl-CoA in animals, but ketone bodies, long-chain fatty acids, citrate, 
and amino acids can also contribute carbons for acetyl-CoA formation. 
Porcine adipose tissue has been found to utilize glucose as a major 
substrate for the formation of acetyl-CoA (Huang and Kummerow, 1966). 
The committed step in cholesterol synthesis is considered to be the 
conversion of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) to 
mevalonate, which is catalyzed by HMG-CoA reductase. HMG-CoA reductase is 
considered to be the major regulatory enzyme in cholesterol biosynthesis 
(Brown and Goldstein, 1986). The regulation of HMG-CoA reductase has been 
reviewed by Scallen and Sanghvi (1983). Cholesterol delivered into the 
cell from lipoproteins suppresses the activity of HMG-CoA reductase, thus 
regulating cholesterol production by the cell (Dietschy, 1984). When the 
rate of cholesterol synthesis was compared with the rate of cellular 
uptake from lipoproteins, Dietschy et al. (1983) concluded that cells will 
alter thm rate of cholesterolgenesis to meet cellular requirements. If 
cholesterol synthesis cannot meet these needs, rates of cholesterol uptake 
or of cholesterol storage as cholesteryl esters may be altered. 
Enterohepatic circulation of bile acids also may be involved in the 
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regulation of hepatic cholesterolgenesis. Interruption of the normal 
enterohepatic cycling of bile acids leads to increased hepatic cholesterol 
synthesis (Myant and Eder, 1961). 
Cholesterol available for absorption in the intestinal tract can come 
from three sources, the diet, bile, and sloughed gut mucosal cells. 
American adults ingest an average of 400 to 500 mg cholesterol per day and 
biliary output of cholesterol ranges from 800 to 1,200 mg per day (Grundy 
and Metzger, 1972), The gut mucosa contributes only a small amount of the 
cholesterol present in the intestinal lumen. Most of the dietary 
cholesterol is associated with triacylglycerol in the diet. A portion of 
the dietary cholesterol may be esterified with fatty acids, but biliary 
cholesterol is entirely nonesterified. Any cholesteryl esters entering 
the intestine are de-esterified rapidly by pancreatic cholesterol esterase 
(Treadwell and Vahouny, 1968). The free cholesterol, mono- and 
diacylglycerols, and fatty acids interact with biliary components 
(phospholipids, cholesterol and conjugated bile acids) in the intestinal 
lumen to form mixed micelles (Hofmann and Borgstrom, 1964). Nonesterified 
cholesterol is solubilized in the hydrophobic center of the micelle. 
Siperstein et al. (1952) discussed the necessity of bile salts for 
cholesterol absorption. The bile salt micelles facilitate absorption of 
cholesterol and other lipids by being small enough to pass into the 
microvillar spaces. The region next to the microvillus is characterized 
by the unstirred water layer, a thin layer of fluid that cannot be mixed 
with the contents of the intestinal lumen. The micelle passes through the 
unstirred water layer to the microvillar surface but does not penetrate 
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the cell membrane. Absorption of cholesterol and other lipids from the 
micelle occurs by passive diffusion through the membrane of the 
microvillus (Westergaard and Dietschy, 1976). 
In the microvillus, cholesterol is re-esterified. The rate of re-
esterification may affect the rate of cholesterol absorption by 
establishing a concentration gradient across the mucosal membrane 
(Westergaard and Dietschy, 1976). Free and esterified cholesterol, along 
with reformed triacylglycerols and phospholipids, are packaged with 
apolipoprotein (apo B^g) in chylomicrons and, to a lesser extent, with 
apolipoprotein B Q^Q (apo B Q^Q) in very-low-density lipoproteins (VLDL) 
(Glickman, 1980). 
The chylomicrons are secreted from the enterocytes into the 
interstitial space, where they enter lacteals and are transported through 
the thoracic duct into the bloodstream. Chylomicrons contain apoproteins 
A-I (apo AI) and A-IV (apo AIV) when secreted and upon entering the 
bloodstream rapidly acquire apoproteins C-II (apo CII), C-III (apo CIII), 
and E (apo E) from other circulating lipoproteins (Havel et al., 1973). 
As chylomicrons pass into the peripheral circulation, they come in contact 
with lipoprotein lipase located at the endothelial surface of capillaries. 
The chylomicronic triacylglycerols undergo hydrolysis facilitated by apo 
CII (Kinnunen et al., 1977). The component fatty acids move across the 
endothelium into the tissue cells for esterification and storage as 
triacylglycerols in fat droplets. After approximately 90% of the 
triacylglycerol has been removed (Havel et al., 1980), the modified 
particle, called a chylomicron remnant, is released from the endothelial 
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surface. The remnants, rich in cholesteryl esters, travel to the liver 
where they are trapped by binding to receptors on hepatocytes. Apo E is 
the ligand for binding the remnant to the receptor. Chylomicron remnants 
are taken into the cell by endocytosis and deliver their contents to 
lysosomes (Jones et al., 1984). Cholesterol from the chylomicron remnant 
then can be used for membrane synthesis, secreted into bile, or returned 
to the circulation after incorporation into other lipoproteins. 
Cholesterol-enriched chylomicron remnants have been found to be potent 
inducers of macrophage conversion into foam cells (Goldstein et al., 
1980). 
The major lipoprotein secreted by the liver is VLDL, a particle rich 
in triacylglycerol and containing apolipoprotein Edge et al. (1985) 
reported that virtually all of the apolipoprotein B secreted from the 
liver of humans in VLDL is apo B Q^Q. The VLDL are smaller than 
chylomicrons and contain more cholesterol and less triacylglycerol than do 
chylomicrons (Scanu and Landsburger, 1980). Shortly after secretion, VLDL 
acquire apo CII and apo E from high-density lipoprotein (HDL). The 
primary function of VLDL are to transport triacylglycerol from the liver 
to adipose and muscle tissue (Havel, 1982), As with chylomicrons, the apo 
CII on VLDL interact with lipoprotein lipase and facilitate the hydrolysis 
of triacylglycerols from VLDL. The lipid-depleted VLDL particles are 
converted to intermediate-density lipoproteins (IDL) (Brown et al., 1981). 
Cholesteryl esters, formed in HDL by lecithin-cholesterol acyltransferase 
(LCAT) from free cholesterol removed from VLDL, are transferred back to 
IDL particles by a plasma cholesteryl ester exchange protein (Fielding and 
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Fielding, 1980), Swine do not have this transfer protein, but Ha et al. 
(1981) state that this cholesteryl ester transfer protein may account for 
only 10 to 20% of the exchange of cholesteryl esters in humans. The net 
result of the triacylglycerol hydrolysis and cholesteryl ester exchange is 
the replacement of the triacylglycerol core of IDL with cholesteryl ester. 
The IDL are released from the capillary wall, and further lipolysis and 
removal of all apolipoproteins except apo B Q^Q result in the conversion of 
IDL to low-density lipoprotein (LDL) (Brown et al., 1981). 
Not all LDL are derived from VLDL. Babiak and Rudel (1987) state that 
kinetic studies in different animal species suggest that only 25 to 75% of 
plasma LDL are derived from plasma VLDL precursors. The remainder of the 
LDL are produced via direct secretion by the liver into the plasma. 
The LDL contain mostly cholesteryl esters in their lipid core, making 
them the major cholesterol transporter in normal plasma. Apo B^QQ 
constitutes more than 95% of the protein in LDL (Malloy and Kane, 1982). 
LDL contain little triacylglycerol. 
The primary route of removal of LDL from circulation is by a receptor-
mediated process in liver and peripheral tissues (Goldstein and Brown, 
1974). Receptors for LDL are found in all body tissues with the exception 
of nervous tissue (Miller, 1979). Studies in rats and rabbits suggest 
that at least two-thirds of the LDL particles cleared from plasma each day 
are taken out of the circulation by the liver, and 80-90% of this is by 
way of the LDL receptor (Brown and Goldstein, 1983b). The liver 
transplantation study of Bilheimer et al. (1984) suggests the same is true 
in humans. 
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The receptors for LDL are located on the cell membrane in areas called 
"coated pits." These regions are characterized by a protein called 
clathrin (Havel, 1986). The LDL bind to the receptors; then, the pits 
internalize and fuse with lysosomes, exposing the LDL to hydrolytic 
enzymes. These enzymes degrade apo to amino acids and hydrolyze 
cholesteryl esters. The LDL-cholesterol in the cell regulates the 
activity of HMG-CoA reductase, controls LDL receptor activity, and 
activates acyl-CoA cholesterol acyltransferase, which catalyzes 
cholesteryl ester reformation and storage of cholesterol as cholesteryl 
ester droplets (Brown and Goldstein, 1986). Familial 
hypercholesterolemia, a condition characterized by defective LDL 
receptors, results in greatly elevated plasma LDL concentration and 
subsequently a shortened lifespan (Brown and Goldstein, 1986). 
Plasma LDL also can be removed by macrophages of the 
reticuloendothelial system (Goldstein and Brown, 1977). Although less 
efficient, this route is of importance when LDL concentrations are 
elevated. When macrophages become loaded with cholesteryl esters, they 
convert to the "foam cells" characteristic of atherosclerotic plaques. 
Goldstein and Brown (1977) estimate that 33 to 66% of plasma LDL are 
degraded by macrophages. 
The fourth class of lipoproteins are the HDL, which are the smallest 
of the lipoproteins. These particles contain mainly cholesteryl esters in 
their neutral lipid core. 
The liver and intestines secrete particles called nascent HDL 
(Hamilton et al., 1976). These disc-shaped lipoproteins are composed of 
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phospholipids and apo AI, All, AIV, C, D, and E. Nascent HDL have a high 
affinity for unesterified cholesterol, which can be acquired from other 
lipoproteins, red blood cells, or other extrahepatic cells. The 
unesterified cholesterol is esterified by lecithin:cholesterol 
acyltransferase (LCAT), with apo AI as a cofactor (Fielding et al., 1972), 
by transferring an acyl group from the phospholipid to the free 
cholesterol. The esterified cholesterol is incorporated into the core of 
the HDL as an oily droplet (Tall and Small, 1980), resulting in a small 
spherical particle called HDLj. 
During circulation, HDLg accumulate additional cholesterol, 
phospholipids and apoprotein subspecies (Tall and Small, 1978). These 
changes can expand HDL^, producing a larger particle called HDLg. The 
fate of the HDLg particle is varied. Core lipids may be removed during 
interaction between HDLg and liver or steroidogenic tissue, resulting in 
smaller HDL. HDLg cholesteryl esters can exchange with VLDL-
triacylglycerol in a reaction mediated by cholesteryl ester transfer 
protein. The triacylglycerols and phospholipids may be hydrolyzed by 
hepatic triglyceride lipase, HDLg may be removed from the circulation by 
direct uptake (Alam et al., 1989), If the HDL particle contains apo E, 
receptor-mediated uptake by the liver is possible, HDLg may provide 
apoproteins to VLDL particles. 
The concept of HDL transporting cholesterol from tissues to the liver 
for excretion was termed "reverse cholesterol transport" by Glomset 
(1968), He postulated that HDL interacts with LCAT, which depletes the 
free cholesterol concentration on the HDL surface as the free cholesterol 
I! 
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is esterified and moved into the core. The decrease of free cholesterol 
on HDL establishes a concentration gradient for free cholesterol between 
the cell membrane and HDL surface. Free cholesterol will move to the HDL, 
be esterified by LCAT, and move to the core. Cholesteryl esters in HDL 
will be transferred by the cholesteryl ester transfer protein to VLDL and 
finally reach the liver as VLDL remnants (Glomset, 1968). 
Roheim (1986) discussed the concept of interstitial HDL formation and 
metabolism. He postulated that apo E and apo AIV in the interstitial 
fluid could interact with the plasma membrane of a cell and result in the 
formation of a discoidal particle. This particle would enter the systemic 
circulation and be exposed to the same metabolic fates as other HDL 
particles. 
Alam et al. (1989) propose another mechanism for the observation that 
increased HDL is associated with decreased risk of atherosclerosis. 
Cholesterol-loaded human monocyte-derived macrophages (MDM), also called 
"foam cells", were evaluated as to the rates of uptake, degradation, and 
resecretion of HDL when compared with the rates in control cells. Binding 
activity of HDL was up-regulated in cholesterol-loaded cells. The HDL 
particles, with and without apo E, were internalized but not degraded. 
Rather, they were resecreted, or "retroendocytosed", as larger HDLg-type 
particles. HDL particles without apo E also had apo E added while 
internalized in the MDM. Thus, the conversion by MDM of HDL^ to HDLg-like 
particles may contribute to reverse cholesterol transport. 
Another lipoprotein, called lipoprotein (a) or Lp(a), is a recently 
discovered risk factor for coronary heart disease (Berg, 1963). 
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Lipoprotein (a) is a cholesterol-rich lipoprotein that generally makes up 
less than 15% of the total plasma cholesterol (Dahlen et al., 1986). 
Lipoprotein (a) consists of one or two molecules of apoprotein (a) linked 
by a disulfide bridge to apoprotein of LDL. Apoprotein (a) is 
structurally similar to plasminogen, the precursor of the fibrin-lysing 
enzyme plasmin. High concentrations of Lp(a) may interfere with the 
fibrinolytic action of plasmin by competing with plasminogen for binding 
to the fibrin clot or by inhibiting the activation of plasminogen. Hajjar 
et al. (1987) reported an accumulation of Lp(a) on the endothelium of 
atherosclerotic coronary arteries but not in normal blood vessels. 
Research on Lp(a) is proceeding actively and may provide a method for 
prediction of risk of cardiovascular disease. 
Dietary Effects 
Dietary cholesterol 
Effects of dietary cholesterol on concentration of plasma cholesterol, 
alterations in plasma lipoproteins, and risk for coronary heart disease 
have been investigated extensively, yet are debated widely. A primary 
reason for these debates is the inconclusive research results that reflect 
differences within a species and between species. Because of this 
variability, the response in humans to dietary cholesterol may not be 
predicted accurately from animal responses. The abundant evidence 
available indicates that increasing dietary cholesterol intake changes the 
various mechanisms that maintain cholesterol homeostasis, including 
cholesterol absorption and synthesis, accumulation of cholesterol in 
tissues, bile acid synthesis, and biliary excretion. 
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Variation in response to dietary cholesterol among individuals within 
a species has been reported for nonhuman primates (Eggen, 1974) and for 
humans (Mistry et ai., 1981). McGill (1979) reviewed the relationship of 
dietary cholesterol to serum cholesterol concentration and to 
atherosclerosis in man. The conclusions from the experiments reviewed 
include: 1) the average serum cholesterol concentration of adults 
increased with increasing dietary cholesterol when the total intake is in 
the range of 0 to 600 mg/day, 2) dietary cholesterol intake above 600 
mg/day resulted in no additional increase in serum cholesterol 
concentration in most subjects, and 3) marked variability among 
individuals in response to dietary cholesterol was observed. Beynen et 
al. (1986) reported that feeding cholesterol-rich diets to animals and man 
resulted in the identification of hypo- and hyper-responders with regard 
to serum cholesterol concentration. The authors concluded that monitoring 
a person's response to diet should be based on relatively large numbers of 
serum cholesterol determinations because of spontaneous, diet-independent, 
within-person fluctuations of the concentration of serum cholesterol. 
The response to dietary cholesterol also varies across species. Wang 
et al. (1957) demonstrated that rabbits fed cholesterol can develop plasma 
cholesterol concentrations in excess of 1,000 mg/100 mL because 
cholesterol absorption greatly exceeds excretion. Quintao et al. (1971) 
reported that in dogs a significant amount of absorbed dietary cholesterol 
was excreted through enhanced formation of bile acids. Kritchevsky (1983) 
showed that cholesterol added to diets produced hypercholesterolemia in 
chickens, rabbits, and some species of primates. Terpstra and Beynen 
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(1984) reported that rabbits, calves, chickens, guinea pigs and obese 
Zucker rats develop a marked elevation in concentration of serum 
cholesterol in response to dietary cholesterol, but this response was not 
seen in mice and lean Zucker rats. 
The rat has been found to not increase serum cholesterol in response 
to dietary cholesterol. Rats can compensate for increased cholesterol 
absorption by decreasing cholesterol synthesis (Morris et al., 1957) and 
by increasing bile acid synthesis. Wilson (1964) reported that the rat is 
able to increase acidic steroid excretion by at least three-fold. 
Temmerman et al. (1989) compared the effect of dietary cholesterol in the 
gerbil and the rat. After four weeks of consuming a diet with 0.2% added 
cholesterol, the gerbils showed a 2.6-fold increase in serum cholesterol, 
whereas the value for the rats was unchanged. Temmerman et al. (1988) 
found no increase in acidic steroid excretion from gerbils when the 
dietary cholesterol was increased from 0.05 to 0,2% of the diet. 
The effects of dietary cholesterol in swine seem to be dependent on 
the concentration of fat in the diet. Reiser et al. (1959) studied the 
effects of feeding high- or low-fat diets supplemented with cholesterol to 
pigs. Pigs fed high-fat diets with added cholesterol had 
hypercholesterolemia, depressed cholesterol synthesis, and excreted less 
bile acids and neutral steroids than did pigs fed low-fat diets 
supplemented with cholesterol. Marsh et al. (1972) reported that pigs fed 
diets containing 49.4% of calories as fat had greatly increased absorption 
of cholesterol and depressed cholesterol synthesis. 
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Changes in lipoprotein concentration in plasma can be induced by 
dietary cholesterol. Diets high in cholesterol and saturated fat increase 
HDL with apo E (HDLg) and LDL and result in the appearance of cholesterol-
rich lipoprotein with fi-electrophoretic mobility (fi-VLDL) (Mahley, 1978). 
Terpstra and Beynen (1984) reported on the changes in concentration in 
serum lipoproteins in several animal species and man after consumption of 
hypercholesterolemic diets. In the chicken and lean Zucker rat, an 
increase in VLDL and IDL particles was observed, with an accompanying 
decrease in LDL and HDL particles. Dietary cholesterol induced an 
increase in the cholesterol concentration of the HDL fraction in humans, 
calves, obese Zucker rats and guinea pigs. Mahley (1978) reported that 
HDLg particles appear in cholesterol-fed dogs, swine, rats, monkeys, and 
possibly man. Dietary cholesterol also induced the formation of &-VLDL 
particles in rabbits, dogs, rats and monkeys (Mahley et al., 1980), and in 
humans and swine (Mahley et al., 1975). Beynen et al. (1984) reported 
that cholesterol feeding increased concentrations of VLDL-, IDL- and LDL-
cholesterol in Yorkshire pigs but not in minipigs. 
Mechanisms have been investigated for the relatively small, yet quite 
variable, increase in concentration of plasma cholesterol in humans after 
increased intake of dietary cholesterol. Wilson and Lindsey (1965) 
concluded that the capacity to absorb cholesterol in man is severely 
limited and that this prevents expansion of body cholesterol pools even 
when the diet is rich in cholesterol. In contrast, Borgstrom (1969) 
presented evidence that large quantities of dietary cholesterol can be 
absorbed. Quintao et al, (1971) reported that up to 1 gram of cholesterol 
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was absorbed in patients fed as much as 3 grams per day, but the 
fractional absorption of cholesterol decreased after intake exceeded 1.5 
grams per day. The authors observed that increased absorption of 
cholesterol resulted in decreased cholesterol synthesis and increased re-
excretion of cholesterol, but not of bile acids. The accumulation of 
cholesterol in body pools occurred in patients who were unable to 
compensate for increased cholesterol absorption (Quintao et al., 1971). 
Nestel and Poyser (1976) found that the sum of these compensating 
mechanisms almost equalled the increase in absorbed cholesterol, but 
increased concentration of plasma cholesterol was prevented only when 
cholesterol synthesis was suppressed. Lin and Connor (1980) concluded 
that the two compensatory mechanisms against cholesterol overloading from 
the diet, decreased cholesterol biosynthesis and increase bile acid 
excretion, were only partially effective in preventing 
hypercholesterolemia. Maranhao and Quintao (1983) stated that decreased 
synthesis is the primary compensatory mechanism and that increased bile 
acid and fecal neutral sterol excretion are secondary mechanisms. The 
authors also concluded that cholesterol accumulation in the body was 
proportional to the amount absorbed, whenever absorption surpassed the 
ability of the compensatory mechanisms. 
Cholesterol intake is only one of several determinants of the 
concentration of plasma cholesterol, particularly in LDL, and the 
concentration of these lipoproteins is positively associated with the 
occurrence of atherosclerotic disease. Lesions similar to human 
atherosclerosis can be induced in several species of animals by feeding 
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cholesterol, usually in conjunction with other dietary components. McGill 
(1979) stated that there is no evidence that low-cholesterol diets are 
harmful and that a decrease of dietary cholesterol, beginning in 
childhood, may produce a modest decrease in total atherosclerotic disease 
and would not cause any other known deleterious effects. 
Dietary calcium 
Calcium is the fifth most abundant element in the animal and human 
body. Ninety-nine percent is present in the skeleton as hydroxylapatite 
(Linder, 1985). The remainder of body calcium is intracellular and 
extracellular, where it is vitally important in directing cell function 
and nerve impulses. Calcium is also an integral component of the blood 
clotting mechanism. 
Calcium absorption from the intestine can occur by two independent 
processes (Bronner, 1987). The first is a saturable, transcellular route 
that is regulated by 1,25-dihydroxyvitamin D via calcium-binding protein 
in enterocytes. This transcellular movement takes place primarily in the 
duodenum and upper jejunum (Pansu et al., 1983). The second process is 
nonsaturable and concentration-dependent, and occurs throughout the length 
of the small intestine by paracellular movement (Bronner et al., 1986). 
Several studies have shown that dietary calcium can decrease the 
concentration of plasma cholesterol. lacono et al. (1960) were one of the 
first groups to report that increased plasma cholesterol during short-term 
starvation in rabbits could be prevented by feeding calcium carbonate, 
lacono (1974) and Dougherty and lacono (1979) reported increased plasma 
cholesterol concentrations in calcium-deficient rabbits. Other studies 
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with rabbits (Yacowitz et al,, 1971; Thakur and Jha, 1981; Renaud et al., 
1983) found a decrease in concentration of plasma cholesterol in those 
rabbits fed supplemental calcium. In young goats, Hines et al. (1985) 
reported a hypocholesterolemic effect of dietary calcium, but Diersen-
Schade et al. (1984) reported that plasma and lipoprotein cholesterol 
concentrations in young goats were not affected by dietary calcium. 
Studies on the hypocholesterolemic effect of dietary calcium in human 
subjects have shown a consistent response. Yacowitz et al. (1965), 
Maibach (1967), and Carlson et al. (1971) demonstrated decreased plasma 
cholesterol concentrations in human subjects consuming supplemental 
calcium with natural diets. Bierenbaum et al. (1972) reported a 25% 
decrease in serum cholesterol in hyperlipemic subjects given two grams of 
supplemental calcium carbonate daily over a period of one year. Albanese 
et al. (1973) reported a "striking and highly statistically significant" 
decrease in serum cholesterol in a group of normal, healthy, elderly 
females given 750 mg supplemental calcium per day. 
Dietary calcium has been purported to have a protective role in 
atherosclerosis. Neal and Neal (1962) fed rabbits a high-fat, high-
cholesterol diet and gave them either distilled or hard water. Rabbits 
drinking hard water, which contains calcium and magnesium salts, had less 
atherosclerosis than did rabbits given distilled water. When distilled 
water was supplemented with calcium carbonate, there was a decrease in 
atherosclerosis. Yacowitz et al. (1971) and Renaud et al. (1983) reported 
that dietary calcium decreased the severity of atherosclerosis in rabbits 
fed diets containing cholesterol. Thakur and Jha (1981) found that yogurt 
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was more protective against atherosclerosis than was either milk or 
calcium, leading the authors to conclude that, although calcium is an 
active factor, other agents also may be present in yogurt. 
The mechanisms by which calcium influences cholesterol metabolism are 
still unclear, but several theories have been proposed. The most 
supported theory is that dietary calcium interferes with the absorption of 
dietary cholesterol and the reabsorption of biliary cholesterol and bile 
acids. Wells and Cooper (1958) found that lactose increased the 
absorption of cholesterol, whereas calcium decreased cholesterol 
absorption. Maibach (1967) found that intravenous administration of 
calcium to humans did not decrease serum cholesterol, whereas patients 
given oral calcium had hypocholesterolemia. He proposed that the 
hypocholesterolemic effect of calcium occurs in the intestine as the 
result of suppressed absorption of cholesterol. Mitchell et al. (1968) 
reported that calcium given to humans in the form of skim milk increased 
fecal excretion of bile acids and neutral steroids. Yacowitz et al. 
(1967) found that total 3-Ji-hydroxysterols increased progressively in 
feces of rats as a function of increased dietary calcium. In contrast, 
Diersen-Schade et al. (1984) observed no differences in the excretion of 
bile acids or neutral steroids in goats fed diets with or without 
supplemental calcium. As discussed earlier, bile acids are necessary for 
optimal absorption of cholesterol and other lipids. In the presence of 
calcium, bile acids may produce insoluble bile salts. Formation of 
calcium cholanates and their subsequent excretion in feces would decrease 
the cholesterol pool (Fleischman et al., 1966), Van der Meer et al. 
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(1985) reported that conjugated bile acids bind to insoluble calcium 
phosphate sediment and are excreted in feces. 
Hypocholesterolemic effects of calcium have been demonstrated by 
Yacowitz et al. (1967) with both saturated and unsaturated dietary fats, 
but the effects were greater when the diet included saturated fat. 
Bhattacharyya et al. (1969) observed a calcium effect only when saturated 
fat was fed and concluded that calcium may interact preferentially with 
saturated fatty acids in the intestine. Pace et al, (1973) stated that 
calcium was effective as a hypolipemic agent when short-, medium-, or 
long-chain saturated fatty acids were fed. Integration of these data with 
reports by Keys et al. (1965) and Hegstead et al. (1965) that show a 
hypercholesterolemic effect of dietary myristic, lauric, and palmitic 
acids strengthens the potential hypolipemic effect of dietary calcium in 
the American diet. 
In contrast to the hypocholesterolemic effects, calcium is known to 
have detrimental effects in atherosclerosis. Calcification is a 
characteristic of atherosclerotic plaques (Moon, 1972). Lachman et al. 
(1977) reported finding calcific deposits in the media of coronary 
arteries of patients with chronic hypercalcemia. This increase in 
arterial calcium is largely intracellular. Strickberger et al. (1988) 
reported a 4.8-fold increase in intracellular calcium in aortas of 
cholesterol-fed rabbits versus control rabbits. Locher et al. (1984) 
showed that increased membrane cholesterol content resulted in increased 
calcium flux into erythrocytes. A recent review by Phair (1988) asserted 
the hypothesis that intracellular calcium is the pathological second 
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messenger of atherogenesis and that diverse risk factors for the 
development of atherosclerosis promote intracellular calcium accumulation. 
If increased intracellular calcium is atherogenic, then treatment or 
prevention of atherosclerosis should be possible with compounds that 
prevent calcium transport from the extracellular to the intracellular 
matrix. Research on specific calcium antagonism was begun by Fleckenstein 
in 1963 (Fleckenstein, 1988), The calcium entry blockers inhibit smooth 
muscle contraction by blocking calcium influx through gated channels 
(Vanhoutte, 1988). The in vivo mechanism of protection of the heart by 
these agents includes vasodilatation, a decrease in myocardial contractile 
activity that decreases energy consumption during ischemia, and prevention 
of the elevation of intracellular calcium, which in turn protects the cell 
and subcellular organelles (Cheung et al., 1986). 
Kramsch et al. (1980) showed that many atherogenic processes are 
dependent on an adequate calcium supply. Kramsch et al. (1981) reported 
that agents that inhibit excessive deposition of calcium into arterial 
walls also inhibit diet-induced atherosclerosis, despite high 
concentrations of serum cholesterol. Fleckenstein et al. (1987) and Henry 
(1988) present comprehensive reviews in which they conclude that 
pharmacological manipulation by calcium antagonists may provide 
vasoprotection and slow the progression of atherosclerosis, but not 
through a hypolipemic mechanism. 
Dietarv vitamin D 
Vitamin D deficiency results in a disease called rickets, the symptoms 
of which have been described since ancient Greece. In the early twentieth 
30 
century, Sir Edward Mellanby demonstrated rickets to be at least in part a 
nutritional disorder that could be treated with cod liver oil. McCollum 
found that the healing factor in cod liver oil was a new fat-soluble 
vitamin, which he called vitamin D. Huldinsky demonstrated that rickets 
could be healed by ultraviolet light. Steenbock observed that ultraviolet 
light induced the formation of vitamin D in fatty portions of diet and of 
skin (DeLuca, 1988). 
These research efforts also laid the foundation for the identification 
of the structures and functions of vitamin D and its metabolites. Two 
primary sources of vitamin D are available to the human body. 
Ergocalciferol, or vitamin Dg, is derived from a common plant steroid, 
ergosterol, and is provided only by dietary sources. Vitamin Dg possesses 
only one-tenth the activity of vitamin Dj in birds, whereas in mammals the 
biological activities are considered equivalent (Norman, 1987). 
Cholecalciferol, or vitamin D^, is produced exclusively from animal 
sources. Vitamin Dj enters the circulation following absorption from the 
small intestine or after synthesis in the skin from 7-dehydrocholesterol 
in a reaction catalyzed by ultraviolet light. Vitamin Dj is transported 
to the liver where it is 25-hydroxylated to become 25 -hydroxyvitamin Dj 
(250HD). The second site of transformation of vitamin is in the kidney 
where 250HD is hydroxylated at the 1 position to 1,25-dihydroxyvitamin 
(1,25(0H)2D) , the most biologically active metabolite. Norman (1987) 
provided references for 28 additional metabolites that have been isolated. 
The principal regulators of 1,25(0H)^) production are parathyroid hormone 
and 1,25(0H)2D. Parathyroid hormone stimulates la-hydroxylase activity 
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through a direct effect on the kidney cell, whereas elevated 
concentrations of 1,25 (OH)gD are known to lead to a decrease in the 
release of parathyroid hormone. 
The secosteroid hormone 1,25(0H)^) will stimulate intestinal calcium 
absorption by increased production of calcium binding protein in 
enterocytes. Schachter and Kowarski (1982) reported the discovery of 
intestinal membrane calcium binding protein, a membrane component of the 
translocation system rather than a cytosolic constituent. The authors 
proposed that 1,25(OH)gD induces a specific alteration in membrane 
phosphatidylcholine content and structure, which leads to a increase in 
membrane fluidity and thereby to an increase in calcium transport rate. 
The mechanism of action of 1,25(0H)^) is considered to be similar to 
that of other steroid hormones. This hormone is known to interact 
noncovalently but stereospecifically with an intracellular receptor 
protein. The steroid-receptor complex then is associated with 
deoxyribonucleic acid (DNA) in the nucleus of target cells, either to (1) 
initiate the synthesis of specific ribonucleic acid (RNA) that encode 
proteins that mediate a variety of biological responses or (2) mediate 
selective repression of gene transcription (Reichel et al., 1989). In 
recent years, 1,25(0H)^) receptors have been found to be ubiquitous in 
tissue distribution, thus opening the possibility for new biological 
functions of vitamin D. Minghetti and Norman (1988) provide an extensive 
list of genes and gene products regulated by 1,25(0H)^D. 
The literature reports on the role of vitamin D in 
hypercholesterolemia are not conclusive. Belkina (1966) reported elevated 
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concentrations of serum cholesterol in children given 600,000 lU vitamin D 
per day, Fleischman et al. (1970) fed 50,000 lU vitamin D daily to adult 
humans for 21 days and observed an average increase in serum cholesterol 
concentration of 28 mg/100 mL. Curcic and Curcic (1975) observed a 
significant increase in concentration of serum cholesterol in rachitic 
children after one month of giving either 6,000, 12,000, or 300,000 lU 
vitamin D per day. Ross and Campbell (1961), Dalderup (1965), and 
Feenstra and Wilkens (1965) also reported increased concentrations of 
serum cholesterol after vitamin D supplementation. Linden (1974) 
concluded that long-term consumption of greater than 1,200 lU vitamin D 
per day may be a cause of myocardial infarction. Carlson et al. (1970), 
however, observed no hypercholesterolemic effect in healthy men fed 1,100 
lU vitamin per day for six weeks. Vik et al. (1979) studied data from the 
Tromso Heart Study and concluded that there was no significant correlation 
between vitamin D status and serum cholesterol concentration in the study 
subjects. 
The effect of vitamin D on hypercholesterolemia also has been studied 
in several animal species. Peng et al. (1978) reported a significant 
increase in concentration of serum cholesterol in squirrel monkeys fed 
diets containing 0.5% cholesterol and supplemented with 500 lU vitamin D 
per day. Gambal and Murphy (1979) observed a 40% increase in serum 
cholesterol concentration in rats fed 400,000 lU vitamin D per day plus a 
1% cholesterol diet only. Fleischman et al. (1972) found that the 
hypocholesterolemic effect of dietary calcium was lessened by the 
inclusion of supplemental vitamin D to the diet. Huang et al. (1977) 
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reported that weanling swine fed vitamin D in combination with dietary fat 
resulted in hypercholesterolemia. The authors also observed that pigs fed 
a low-fat basal diet supplemented with vitamin D did not develop 
hypercholesterolemia, thus suggesting a synergism between dietary fat and 
vitamin D. Jurgens et al. (1970) reported an increase in concentration of 
serum cholesterol in pigs fed 1,100 lU vitamin D/kg diet when the diet 
contained safflower oil but not when the diet contained coconut oil. 
Truswell (1978) reviewed several studies that also demonstrated that 
vitamin D is hypercholesterolemic in animals. 
In contrast to studies demonstrating an increase in serum cholesterol 
concentration when vitamin D is fed, other studies show no effect. 
Fleischman et al. (1968) found that vitamin D did not influence the 
hypolipemic effect of calcium in rats. Jurgens et al. (1971) reported 
that the inclusion of excess vitamin D in a cholesterol-supplemented diet 
resulted in decreased serum cholesterol concentrations in rats. Mines et 
al. (1985) also found no hypercholesterolemia in goats fed excess vitamin 
D. 
Theories on the mechanism by which vitamin D affects cholesterol 
metabolism have been presented. Huang et al. (1977) postulated that 
vitamin D in the diet may result in increased absorption of calcium in the 
proximal portion of the small intestine. This would allow less calcium to 
complex with dietary lipids and form insoluble complexes in the intestinal 
lumen. Thus, more dietary lipid, including cholesterol, would be 
absorbed. Gupta et al. (1989) reported that 250HD decreased cholesterol 
synthesis in rat intestinal epithelial cell culture by inhibiting the 
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activity of HMG-CoA reductase and lanosterol 14a-deinethylase, The 
activity of lanosterol 14a-demethylase also was inhibited by 1,25(0H)^ ], 
but the activity of HMG-CoA reductase was stimulated as much as 50% in one 
cell line. Jurgens and Peo (1970) suggested that vitamin D may play a 
homeostatic role by increased retention of cholesterol in the liver. 
Jurgens et al, (1971) stated that vitamin D may affect cholesterol 
absorption by competition or by interference with the esterification of 
cholesterol in its passage from the intestinal lumen into lymph. 
Excess vitamin D has been shown to increase atherosclerosis. 
Vanderveer (1931) described a type of arteriosclerosis caused by excess 
vitamin D. Harrison (1933) characterized two distinct types of 
arteriosclerosis, cholesterol-dependent and vitamin D-dependent. Peng and 
Taylor (1980) reviewed the literature on the topic of vitamin D effects on 
arteriosclerosis. The authors concluded that long-term consumption of 
excess vitamin D may be a major cause of atherosclerosis, with cholesterol 
intake and serum cholesterol concentrations playing an important secondary 
role. The feeding of large doses of vitamin Dg in conjunction with high-
cholesterol diets has been found to result in atherosclerotic lesions in 
arteries of rats (Bajawa et al., 1971; Gambal and Murphy, 1979; Okawa et 
al., 1980; Kunimoto et al., 1981) and rabbits (Mass et al., 1969). Huang 
et al. (1977) reported that aortas from pigs fed vitamin D and high-fat 
diets had more fatty streaking, raised lesions, and smooth muscle cells in 
the proliferative, synthetic state than did pigs fed either vitamin D or 
supplemental fat alone. Kummerow et al. (1976) reported that aortas from 
pigs fed 220,000 lU vitamin D per kilogram of diet for five weeks had more 
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localized collections of fibrous and amorphous extracellular materials as 
well as atypical smooth muscle cells than did pigs fed 1,430 lU vitamin 
D/kg diet. Other studies with pigs also found coronary atherosclerosis 
and smooth muscle cell degeneration to have been vitamin D-induced (Kamio 
et al., 1977; Taura et al., 1978, 1979). Toda et al. (1985) reported that 
pigs fed 4,400 lU vitamin D/kg diet for four months showed areas of 
intimai thickening in coronary arteries. The thickened areas contained 
numerous lipid-containing cells and degenerate cells without stainable 
lipid. Peng et al. (1978) reported that squirrel monkeys fed a mild 
excess of vitamin D (500 lU/day or 1,000 lU/day) with and without 
cholesterol for ten to 18 months had arterial damage, and the most 
significant lesions occurred in monkeys receiving a combination of 500 lU 
vitamin D/day plus a 0.5% cholesterol diet. Mines et al. (1985) reported 
that goats fed a high-vitamin D, high-calcium diet developed 
atherosclerosis, but goats fed either high-vitamin D or high-calcium diets 
had less atherosclerosis. 
Recent research has shown the interaction of vitamin D with the immune 
system (Rigby, 1988). Vitamin D receptors have been identified on rat 
aortic vascular smooth muscle cells (Kawashima, 1987) and on 
monocyte/macrophages (Prowideni et al., 1983). Manolagas et al. (1985) 
reviewed studies that showed that l,25(OH)2D promoted the differentiation 
of monocyte precursors toward macrophages. Bar-Shavit et al. (1981) 
reported that chemotaxis and phagocytosis of peritoneal macrophages from 
vitamin D-deficient mice were decreased, whereas incubation of cells with 
1,25(0H)^) restored their normal functionality. Abe et al. (1981) 
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demonstrated that immature mouse myeloid leukemia cells differentiated to 
more mature macrophage-like cells after treatment with 1,25(0H)^ 3. The 
expression of macrophage-related enzymes increased and phagocytic activity 
was enhanced. Shezen and Goldman (1987) found that physiological and 
pharmacological concentration of 1,25(0H)^) increased the proliferation 
and function of rat macrophage progenitor cells. These recent findings 
could have important implications on future research on atherosclerosis, a 
condition characterized by the accumulation of active macrophages in the 
arterial wall. 
Bile 
Secretion of bile, the major excretory route for cholesterol from the 
body pool, is a unique function of the liver and represents one of its 
primary activities. The liver is organized into lobules within which 
blood flows past hepatocytes via sinusoids from branches of the portal 
vein to the central vein of each lobule. Hepatocytes closest to the 
afferent blood supply are termed Zone 1 or periportal cells. These cells 
are exposed to the greatest concentration of nutrients. Periportal cells 
remove most of the incoming bile acids and make the greatest contribution 
to bile salt-dependent flow (Gumico and Miller, 1981). The cells closest 
to the efferent blood outflow are termed Zone 3, periveinous, or 
centrilobular cells. Hepatocytes of Zone 3 may contribute significantly 
to the secretion of bile salt-independent flow (Gumico and Miller, 1981). 
Each liver cell is apposed to several bile canaliculi. The canaliculi 
merge to form the right and left hepatic ducts, which join outside the 
liver to form the common hepatic duct. The hepatic duct joins with the 
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cystic duct to form the common bile duct. The cystic duct shunts bile 
between the common bile duct and the gall bladder. 
Water and electrolytes are secreted into the canalicular lumen across 
an electrochemical gradient maintained by the active hepatic secretion of 
osmotic substances. Several experimental and clinical studies have 
established that hepatic secretion of bile acids is the major determinant 
of bile flow (Blitzer and Boyer, 1982). When bile flow is plotted against 
bile acid secretion, a linear positive relationship between these two 
variables can be observed. If the regression line is extrapolated to zero 
bile acid secretion, a positive intercept with the ordinate is found, 
which gives the bile acid-independent flow (BAIF); the slope of the line 
gives the bile acid-dependent flow (BADF) (Forker, 1977). The fraction of 
each of these flows varies considerably in different animal species. In 
man, BADF represents about 60% of total canalicular bile flow, the 
remaining 40% being independent of bile acid secretion (Okolicsanyi et 
al., 1986). 
Bloch et al. (1943) showed the existence of a direct metabolic 
relationship between cholesterol and bile acids when he demonstrated that 
cholesterol was converted into labeled cholic acid in a dog with 
cholecystonephrostomy. Siperstein et al. (1952) observed that labeled 
cholesterol fed to rats could be found mainly in the bile acid fraction of 
bile and feces. Other studies showed that as much as 60-90% of 
intravenously injected labeled cholesterol was metabolized to bile acids 
in the rat, with the remainder being excreted as neutral steroids in feces 
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(Chaikoff et al., 1952; Slperstein and Chaikoff, 1952; Friedman et al., 
1953). 
Cholesterol is the obligatory precursor of bile acids, and the liver 
is the only site of bile acid formation (Danielsson, 1973). Bjorkhem 
(1985) reviewed research that led to the conclusion that the initial and 
rate-limiting reaction in bile acid synthesis is the 7a-hydroxylation of 
cholesterol to form 7a-hydroxycholesterol. This reaction is catalyzed by 
the microsomal enzyme cholesterol 7@-hydroxylase. The substrate for la-
hydroxylase is free, unesterified cholesterol and not cholesteryl esters 
(Ogura et al., 1971). Newly synthesized cholesterol has been reported to 
be the preferred substrate pool (Mitropoulos et al., 1974; Schwartz et 
al., 1975). According to Kim, et al. (1975), swine do not distinguish 
between cholesterol of dietary or endogenous origin in the synthesis of 
bile acids. The steps after 7a-hydroxylation involve oxidation of the 
hydroxyl group at C-3 and isomerization of the double bond from C-5,6 to 
C-4,5, which yields 70!-hydroxy-4-choiestene-3-one. This compound is the 
last metabolic intermediate common to the synthesis of both cholic and 
chenodeoxycholic acids. Hanson and Pries (1977) outlined the multi-step 
reaction from 7a-hydroxycholesterol to either cholic or chenodeoxycholic 
acid. 
Members of the Suidae family, which includes domestic swine, produce 
little cholic acid but have ôa-hydroxylase that acts upon chenodeoxycholic 
acid to produce the trihydroxy acid called hyocholic acid (Hasselwood, 
1964). Bostrom (1986) has characterized and partially purified microsomal 
6a-hydroxylase from pig liver. 
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Bile salts are conjugated in the liver with glycine or taurine to 
decrease their toxicity, Hepner et al. (1972) showed that the daily 
turnover of the glycine moiety was more than three times faster than was 
steroid turnover, indicating that conjugated bile salts are deconjugated 
by bacterial enzymes before they are absorbed by the intestine. The ratio 
of glycine-to-taurine in conjugated bile salts in man is three-to-one. 
This ratio can increase when bile salt synthesis is increased and is 
decreased with increased dietary taurine (Sjovall, 1959). 
In addition to being an excretory route for cholesterol and several 
other natural compounds, many commonly used drugs also are eliminated 
through the bile following hepatic biotransformation. Okolicsanyi et al. 
(1986) presented an extensive review on the effects of drugs on bile flow 
and composition. A variety of drugs can influence bile flow and 
composition with the result of cholestasis, whereas others are potent 
choleretics. Much of the recent interest in bile flow and composition has 
concentrated on the bile acid sequestrants. These compounds bind bile 
acids in the gut and thus interrupt their enterohepatic recirculation. 
This, in turn, has a major impact on lipid and lipoprotein metabolism in 
the liver, resulting in changes in the concentrations of plasma 
lipoproteins. Reviews of clinical studies and mechanisms of action of 
bile acid sequestrants have been presented by LaRosa (1989) and Shepherd 
(1989). The interruption of bile recirculation has been shown to increase 
the activity of three hepatic enzymes : phosphatidic acid phosphatase, 
cholesterol 7û!-hydroxylase, and HMG-CoA reductase. Angelin et al. (1981) 
demonstrated an increase in activity of hepatic phosphatidic acid 
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phosphatase in cholestyramine-treated rats and in rats with surgical 
biliary diversion. An increase in plasma triacylglycerol concentrations 
is seen commonly during sequestrant resin therapy, but concentrations 
generally do not exceed the upper limit of the normal range (Shepherd, 
1989). Dowling et al. (1970) showed that a gradual increase in the 
percentage of interruption of the enterohepatic circulation in Rhesus 
monkeys resulted in a gradual increase in the rate of bile salt synthesis 
until a maximum was reached. The increased activity of cholesterol Icx-
hydroxylase produces the desired therapeutic effects of bile acid 
séquestrants, which include increased hepatic synthesis of bile acids and 
a consequent decrease of intracellular stores of cholesterol in 
hepatocytes (Packard and Shepherd, 1982). The decrease of intracellular 
cholesterol stores caused by cholestyramine was found to increase the 
activation of LDL receptors in patients with heterozygous familial 
hypercholesterolemia (Shepherd et al., 1980). The third enzyme to be 
increased in liver is HMG-CoA reductase, which also responds to decreased 
intracellular cholesterol. This safety mechanism would attempt to stop 
the depletion of cholesterol necessary to meet the increased synthesis of 
bile acids. Grundy et al. (1985) provided evidence that the combination 
of a bile acid sequestrant and an HMG-CoA reductase inhibitor produced 
complementary and additive effects on decreased concentration of plasma 
cholesterol. This decrease in plasma cholesterol concentration 
theoretically should have an ameliorative effect on the symptoms of 
atherosclerosis. Shepherd (1989) concluded that the bile acid 
sequestrants not only retarded the progression of atherosclerosis but also 
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limited the clinical consequences in a number of studies. The author also 
stated that sequestrant resins have an admirable record of both safety and 
efficacy and will remain in the foreseeable future an important part of 
the therapy for hypercholesterolemia. 
Domestic Fig as Model 
The selection of an animal for the study of human disease and 
physiology should be based on appropriate physiological comparisons. 
Domestic swine have been evaluated extensively as models for many aspects 
of human physiology (Pond and Houpt, 1978; Dodds, 1982; Hughes, 1986; 
Tumbleson, 1986; Miller and Ullrey, 1987). The area of interest in this 
dissertation is the use of swine as animal models for cholesterol 
metabolism, bile secretion, and atherosclerosis in humans. Slaughterhouse 
surveys (Gottlieb and Lalich, 1954) and examination of pigs used in long-
term experiments (Skold and Getty, 1961) have demonstrated that the pig 
develops atherosclerotic plaques in the heart and blood vessels similar to 
those observed in humans. Ratcliffe et al. (1970) reported lesions of 
atherosclerosis in swine of three groups to be morphologically identical 
to the corresponding stages of atherosclerosis in humans and concluded 
that swine can replace nonhuman primates as subjects for studies of 
atherosclerosis. White et al. (1986) chose the pig as their animal model 
to study ischemic heart disease because the anatomy of the coronary 
arteries, the heart size, and the relative heart weight to body weight are 
similar to those of humans. 
Pigs, like humans, are omnivores. In addition, Diersen-Schade et al. 
(1985) showed that pigs can be fed successfully diets resembling human 
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diets. Plasma lipoproteins and apolipoproteins are similar to those found 
in human plasma including patterns observed after cholesterol feeding 
(Mahley et al., 1975; Mahley, 1978). Nutritionally manipulated pigs do 
develop atherogenic symptoms when fed high cholesterol, high fat diets and 
do respond to other dietary influences such as the more atherogenic 
influence of animal proteins compared with vegetable proteins (Kim et al. 
1978). 
Because of the number of offspring per parity, swine littermate groups 
of the same sex can be used as experimental replications, thereby 
decreasing genetic variation across treatments. Domestic swine are also 
relatively inexpensive animal models. 
Use of the pig, however, is not a panacea in the search for an 
appropriate model for human physiology. Patel et al. (1975) reported that 
the synthesis and secretion of VLDL are more extensive in humans. Human 
plasma contains a cholesteryl ester transfer protein that transports 
cholesteryl esters between lipoprotein fractions (Hopkins and Barter, 
1980). Ha and Barter (1982) reported that pigs have cholesteryl ester 
transfer activity that is only 19% of that of man. Swinkels and Demacker 
(1988) conclude that, although some differences in LDL subfractions 
between pigs and humans were observed, the pig is a suitable animal model 
for further studies of the cause and consequences of LDL heterogeneity. 
The protocols of many animal experiments require surgical procedures 
to be performed. The animal model, therefore, must be appropriate not 
only physiologically but also able to be modified surgically. The 
adaptability of the pig to surgical research has been described well by 
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Swindle (1983), A study of the relationship between nutrition and bile 
secretion in the pig requires the flexibility to make multiple samplings 
or total collection of the bile and reinfuse bile into the animal to 
maintain a steady-state condition. Several laboratories have reported 
successful surgical techniques to complete these requirements (Juste et 
al., 1979; Sambrook, 1981; Thurmon et al., 1987). 
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SECTION 1. EFFECT OF DIETARY CALCIUM AND CHOLECALCIFEROL 
ON BILE FLOW AND COMPOSITION IN YOUNG PIGS 
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ABSTRACT 
Fifty-four crossbred, castrated male pigs with an average initial 
weight of 10.2 kg were fed diets containing either 1 or 3 times the daily 
requirement of calcium and 1, 5 or 25 times the daily requirement of 
cholecalciferol in a 2 X 3 factorial design. During week 6, pigs were 
fitted with femoral artery, coimnon bile duct and re-entrant duodenal 
catheters. Eighteen pigs died during or after surgery, giving a mortality 
rate of 33%. Causes of death included intestinal blockage, euthanasia 
after catheter failure, gastric ulcer, infection and death during surgery. 
Body weight of pigs at weeks 7 and 8 were greater (P<0.10) than week 6 
weights, indicating that the pigs were growing after surgery. Body weight 
gain from week 6 to week 8 was greater (P<0.10) for pigs fed excess 
calcium than for pigs fed the recommended amount of calcium. 
Concentrations of plasma triacylglycerol were decreased at week 8 for pigs 
fed excess calcium (P<0.05) or excess cholecalciferol (P<0.10). 
Concentrations of plasma phospholipid decreased after week 6 (P<0.10) and 
continued to decrease at week 8 (P<0.05). Concentrations of plasma 
cholesterol decreased after week 6 (P<0.10) but were not different between 
weeks 7 and 8. Pigs fed excess calcium had decreased (P<0.10) plasma 
cholesterol concentrations at week 8 compared to pigs fed the recommended 
amount of calcium. Concentrations of LDL- and HDL-cholesterol did not 
show significant calcium or cholecalciferol effects at the three weeks 
sampled. Concentrations of HDL-cholesterol were less (P<0.01) at weeks 7 
and 8 but week 7 was not significantly different from week 8. After week 
8, bile was collected for 48 hours from the 36 remaining pigs (six per 
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treatment). Pigs fed excess calcium had less (P<0.01) bile flow (52 
mL/hr) than did pigs fed diets containing the recommended amount of 
calcium (70 mL/hr). Bile flow was continuous but variable during the 48-
hour sampling period. Pigs fed excess calcium had greater (P<0.05) 
concentration of bile acids in bile. Concentrations of biliary 
cholesterol and phospholipid were not affected by dietary calcium. 
Output of biliary cholesterol during the 48-hour sampling period was 
greater (P<0.05) for pigs fed the recommended amount of calcium. Output 
of biliary bile acids and phospholipids was nonsignificantly greater for 
pigs fed the recommended amount of calcium. Dietary cholecalciferol did 
not affect the bile flow or concentration or secretion of biliary lipids. 
In conclusion, excess dietary calcium caused decreased bile flow, 
increased concentration of biliary bile acids, and decreased secretion of 
biliary lipids in young pigs. 
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INTRODUCTION 
Use of the domestic pig as a model for the study of human physiology 
has been evaluated extensively (Pond and Houpt, 1987; Dodds, 1982; 
Tumbleson, 1986; Miller and Ullrey, 1987). Pond and Houpt (1978) stated 
that the digestive physiology of the pig resembles the human in more ways 
than in any other nonprimate mammalian species. Pigs, like humans, are 
omnivores. In addition, Diersen-Schade et al. (1985) showed that pigs can 
be fed successfully diets resembling human diets. 
Dietary calcium is hypocholesterolemic in humans (Bierenbaum et al., 
1972), rats (Yacowitz et al., 1967), rabbits (Yacowitz et al., 1971), and 
goats (Mines et al., 1985). Dietary vitamin D, however, increased plasma 
cholesterol concentration in humans (Fleischman et al., 1970), rats 
(Gambal and Murphy, 1979), squirrel monkeys (Peng et al., 1978) and swine 
(Huang et al., 1977). 
Cholesterol is removed from the body primarily through conversion to 
bile acids and biliary cholesterol, which are excreted in feces. A 
variety of compounds influence bile flow and composition (Okolicsanyi et 
al., 1986). Dietary calcium and/or vitamin D may exert their effects on 
concentration of plasma cholesterol through altered secretion of bile 
acids or biliary cholesterol. The objectives of this study were to 
determine- the effects of dietary calcium and cholecalciferol, alone or in 
combination, on (1) response to and recovery from major abdominal surgery 
and (2) bile flow and composition in young pigs. 
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MATERIALS AND METHODS 
Fifty-four crossbred, castrated male pigs with an average initial 
weight of 10,2 kg at approximately six weeks of age were allotted randomly 
to six dietary treatments (nine pigs per treatment). The experimental 
design was a 2 x 3 factorial arrangement with two concentrations of 
calcium and three concentrations of cholecalciferol supplemented to a 
basal diet. Pigs were housed in an environmentally controlled facility in 
individual pens on sawdust-covered floors. Water was available ad libitum 
from automatic nipple waterers. Pigs were weighed weekly, and daily feed 
intake was adjusted to 4.5% of body weight, dry-matter basis. Pigs were 
fed twice daily throughout the 8-week feeding portion and the 48-hour 
sampling portion of the study. 
Dietary ingredients are shown in Table 1. The calcium concentrations 
were one (IXCa) and three (3XCa) times the daily requirement for young 
pigs (NRG, 1979). The cholecalciferol concentrations were (1) one times 
(IXD), (2) five times (5XD) and (3) 25 times (25XD) the daily requirement 
for young pigs (NRG, 1979). Concentrations of calcium and cholecalciferol 
in the IXCa-lXD diet were 0.65% and 0.5 /lg/100 g, respectively. Diets 
containing the recommended daily amount of calcium (IXCa) also contained a 
fine-mesh, calcium-free silica sand to make each diet isonitrogenous, 
isocaloric and similar in consistency. Gholecalciferol was added to the 
diets as a suspension of crystalline cholecalciferol in minimal amount of 
soybean oil. Powdered egg yolks were added to the diets as a source of 
cholesterol. The concentration of cholesterol in each diet was calculated 
to be fed at 20 mg/kg body weight (0.046% of diet) daily. Finely ground 
TABLE 1. Ingredient composition of diets 
Diet*'t'C 
IXCa IXCa IXCa 3XCa 3XCa 3XCa 
Ingredient WD 5XD 25XD m 5XD 25XD 
Calcium carbonate^ 0.3 0.3 0.3 3.6 3.6 3.6 
(% dry matter) 
Silica sand (100 mesh)® 3.3 3.3 3.3 0 0 0 
(% dry matter) 
Cholecalciferol^  0.5 2.5 12.5 0.5 2.5 12.5 
(Mg/100 g feed) 
^IXCa and 3XCa refers to one and three times daily dietary requirement of calcium; IXD, 5XD and 
25XD refers to one, five and 25 times the daily requirement of cholecalciferol. Values are means 
for six pigs per diet. 
^All diets contained the following (on a % dry matter basis): ground shelled com, 37.0; dried 
skim milk, 40.5 (donated by United States Department of Agriculture, Agricultural Stabilization and 
Conservation Service, courtesy of R. H. Sindt); soybean oil, 16.4 (donated by Central Soya Co., 
Inc., Fort Wayne, IN, courtesy of D. Strayer); egg yolk, 1.6 (used as a source of cholesterol, 
donated by Henningsen Foods, Inc., Omaha, NE, courtesy of D. H. Bergquist) and vitamin and mineral 
mix, 0.9 (donated by Feed Specialties Co., Des Moines, lA, courtesy of L. Russell. Guaranteed 
analysis (per kg.): 416 g rice hulls, 288 g sodium chloride, 143 g 1-lysine-HCl, 63.0 g choline 
chloride, 45.4 g ferrous sulfate monohydrate, 19.3 g zinc oxide, 10.9 g manganous oxide, 3.80 g 
niacin, 2.88 g riboflavin, 2.05 g d-calcium pantothenate, 2.70 g cuprlc oxide, 1.50 g menadione 
bisulfite complex, 1.26 g dl-alpha-tocopheryl acetate, 1.15 g cyanocobalamin, 0.85 g retinyl 
acetate, 125 mg biotin, 75 mg ethylenediamine dihydroiodate and 25 mg folic acid). 
^Diets for all animals were supplemented with 3.5g psyllium seed per day, donated by Feed 
Specialties, Des Moines, lA, courtesy of L. Russell. 
F^re-Flo Alden, Ground Limestone, Iowa Limestone Co., Des Moines, lA. Guaranteed analysis: 
calcium carbonate, not less than 98.00%; calcium, not more than 39.60% and not less than 39.20%. 
^Donated by 3M, Ames, lA, courtesy of G. Stevens. 
^Sigma Chemical Co., St. Louis, MO. 
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psyllium seed was added as a fiber source at 3.5 grams per head daily, the 
recommended dosage of Metamucil" for humans by Proctor and Gamble 
(Cincinnati, OH) to prevent constipation. On a dry-matter basis, each 
diet contained 3.98 kcal ME/g, 18.2% protein and 19% fat. 
During week 6, each pig was fitted with a femoral artery catheter, 
bile duct catheter and re-entrant duodenal catheter. All surgeries were 
performed under the guidelines of the American Association of Laboratory 
Animal Care. Anesthesia was induced and maintained with halothane inhaled 
through a mask. To implant the bile duct and re-entrant duodenal 
catheters, a mid-line incision was made from the xyphoid process to the 
umbilicus. The biliary system was isolated, and the cystic duct was 
ligated at its junction with the common bile duct. The gall bladder was 
drained through a 20-gauge needle inserted into the apex. The common bile 
duct was ligated at the duodenum, leaving the ends of the ligature loose 
for later use. Another silk thread was placed around the common bile duct 
for later use in securing the catheter in the proper location. A small 
cut was made across the common bile duct approximately equidistant from 
the cystic duct junction and the duodenum to accommodate the catheter. 
The catheter was inserted through the opening until the tip was past the 
cystic duct into the hepatic duct. The catheter was secured with the silk 
thread previously inserted around the common bile duct. To maintain 
alignment of the catheter with the common bile duct, the ends of the tie 
near the duodenum were used to secure the catheter to the common bile duct 
at the duodenum. Bile was allowed to flow freely from the catheter during 
the remainder of the surgical procedure. 
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The re-entrant duodenal catheter was prepared and inserted as 
described by Davis et al. (1985), with the exception that the catheter was 
placed opposite the sphincter of Oddi, and the tip was inserted to a point 
5 cm distal to the sphincter. Both catheters were exteriorized through 
the right body wall 10 cm dorsal to the incision. The ends of the 
catheters were connected with a plastic Y-connector in which one arm of 
the Y was capped with an injection cap. The peritoneal cavity was flushed 
with sterile 0,15 N NaCl solution, and two antibiotic tablets 
(tetracycline hydrochloride) were inserted into the cavity. The incision 
was closed in layers. Pocket-type bandages were glued over the 
exteriorized catheters and further secured with elastic bandage tape. 
These bandages allowed easy access to the catheters for flushing and 
sampling. Antibiotic (penicillin-dihydrostreptamycin, 5 mL) was 
administered intramuscularly daily for three days following surgery. Bile 
catheters were checked for flow rate every day for three days and then 
every other day until the sampling phase of the study. 
Other pigs weighing approximately 25 kg also were implanted with the 
bile duct and re-entrant duodenal catheters. These pigs were fed 
treatment diets and maintained as bile-donor pigs. Bile from these pigs 
was collected daily and stored at 4°C until needed for reinfusion into 
test pigs. Artificial bile has been used for in vitro studies (Uematsu et 
al., 1984) but was not used in this study because of the large volume 
needed and the prohibitive cost. 
Bile samples (10 mL) were collected over a 48-hr period and stored at 
-20°C until analyzed. The sampling times were 2, 4, 8, 12, 18, 24, 36 and 
53 
48 hours, as dictated by the protocol of blood sampling times for another 
portion of the study. Between sampling times, bile was allowed to flow 
freely from the bile duct catheter into a graduated collecting bottle. At 
each sampling time, the volume collected was recorded, and a 10-mL aliquot 
was stored at -20°C until analyzed. Bile previously collected from bile-
donor pigs was pumped into the re-entrant duodenal catheter at a rate 
approximately equal to the rate of bile flow out of the pig. This allowed 
each pig to be in a steady-state condition with regard to bile acid 
metabolism. 
Bile samples were analyzed for concentration of total bile acids, 
cholesterol and phospholipids. Total bile acids were determined 
enzymatically by using 3a-hydroxysteroid dehydrogenase (HSD) (Sigma 
Chemical Co., St. Louis, MO) as the catalyst and cholic acid as the 
standard (Green and Kellogg, 1987). Bile was diluted 1:80 with methanol 
before the addition of other reaction reagents. Reducing equivalents 
produced by HSD reaction with bile acids were transferred by diaphorase to 
nitroblue tetrazolium, resulting in a blue color that was proportional to 
the concentration of bile acids in the sample. 
Bilirubin in bile interferes in peroxidase-coupled enzymatic 
procedures involving the spectrophotometric measurement of hydrogen 
peroxide (Witte et al., 1978). This interference was removed by pre-
treating the sample with bilirubin oxidase before addition of the reagents 
of the enzymatic assay for concentration of cholesterol (Sigma Cholesterol 
kit No. 352, Sigma Chemical Co., St, Louis, MO). Bilirubin oxidase 
catalyzes the conversion of bilirubin to biliverdin, which does not have 
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an interfering absorbance at the same wavelength as the chromogen used in 
the enzymatic assay. The procedure developed for determination of 
cholesterol concentration in bile has been accepted for publication 
(Luhman et al,, 1990). 
Phospholipids in bile were determined by the method of Takayama et al. 
(1977) which measures choline released from phosphatidylcholine, the 
primary phospholipid in bile. A value of 775 was used as an average 
molecular weight of phospholipid for calculation of molar concentration of 
phospholipid in bile. 
Data were analyzed by the general linear model (GLM) procedure of SAS 
(1982) for main effects of calcium and cholecalciferol, and for calcium by 
cholecalciferol interaction in a 2 x 3 factorial arrangement of a 
completely randomized design. Data are expressed as group means with 
pooled standard errors of the mean. Data from biochemical measurements 
made on pigs before and after surgery also were analyzed for week effects 
by orthogonal contrasts and for treatment by week interaction. 
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RESULTS 
The results of the first six weeks of the feeding period have been 
reported by Foley et al. (1990). Briefly, excess dietary calcium 
significantly decreased the body weight gain of pigs. Excess dietary 
calcium increased the phospholipid concentration in the plasma, but not in 
any of the lipoprotein fractions. Calcium variation had no effect on 
cholesterol, triacylglycerol or protein concentrations in plasma and in 
lipoprotein fractions. Dietary cholecalciferol variation had no effect on 
body weight gain or concentrations of cholesterol, phospholipid, 
triacylglycerol or protein in plasma and in lipoprotein fractions. 
The mortality rate of the bile duct/duodenal cannulation surgeries was 
33%. The 18 pigs that did not complete the study died from the following 
causes: six from intestinal blockage that resulted from adhesion of the 
small intestine to other organs, four from euthanasia following catheter 
failure, three from gastric ulcer, three from infection and two died 
during surgery. All pigs that completed the study period had some amount 
of adhesion of the small intestine to other organs and to the body wall. 
Data presented in Table 2 show the changes in body weight and 
concentrations of plasma triacylglycerol, phospholipid and cholesterol, 
and LDL- and HDL-cholesterol from just before surgery through two weeks 
after surgery. Body weight of pigs fed excess dietary calcium was less 
(P<0.05) at week 6 than that of pigs fed the NRC-recommended amount of 
calcium. No differences in body weight were seen across treatments in 
week 7 or week 8. Dietary calcium and cholecalciferol did not 
significantly affect body weight at week 7 or week 8. Weeks 7 and 8 
TABLE 2. Surgery effects on body weight and concentration of plasma trlacylglycerol, 
phospholipid, and cholesterol, and low- and high-density lipoprotein-cholesterol 
Diet* 
IXCa IXCa iXCa 3XCa 3XCa 3XCa 
Item IXD 5XD 25XD IXD 5XD 25XD SEM^ 
Body weight 
week 6^ '^  30 
week 7® 29 
week 8 31 
Plasma 
trlacylglycerol 
week 6 29 
week 7 35 
week 39 
Plasma phospholipid 
week 6® 152 
week 7^ 103 
week 8 81 
Plasma cholesterol 
week 6® 113 
week 7. 101 
week 8^  91 
LDL cholesterol 
week 6 50 
week 7 44 
week 8 56 
kg 
29 31 26 
29 32 29 
32 35 30 
mg/100 mL 
30 21 27 
35 32 28 
27 32 31 
137 124 124 
124 126 90 
102 92 78 
107 85 92 
80 96 74 
88 92 78 
48 42 57 
41 52 47 
44 49 47 
24 26 1 
26 28 1 
29 31 1 
28 29 2 
25 39 2 
24 17 2 
133 159 7 
97 93 7 
84 90 6 
108 105 5 
97 73 5 
81 77 3 
52 36 3 
45 35 3 
45 35 2 
HDL cholesterol 
week 6ë 36 37 28 40 34 42 2 
week 7 24 20 31 27 31 30 2 
week 8 26 W 29 31 26 22 1 
^IXCa and 3XCa refers to one and three times daily dietary requirement of calcium; IXD, 5XD, 
and 25XD refers to one, five and 25 times the daily requirement of cholecalciferol. Values are 
means for six pigs per diet. 
^SEM - standard error of the mean. 
C^alcium effect (P<0.05). 
^Week 6 vs. week 7 and week 8 (P<0.10). 
®Week 7 vs. week 8 (P<0.10). 
C^holecalciferol effect (P<0.10). 
SWeek 6 vs. week 7 and week 8 (P<0,01). 
W^eek 7 vs. week 8 (P<0.05). 
C^alcium effect (P<0.10). 
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weights were greater (P<0.10) than week 6 weights, and week 8 weights were 
greater (P<0.10) than week 7 weights, indicating that the pigs were 
growing after surgery. Body weight gain from week 6 to week 8 was greater 
(P<0.10) for pigs fed 3XCa diets than for pigs fed IXCa diets. Dietary 
cholecalciferol did not significantly affect body weight changes during 
the three-week period. Concentrations of plasma triacylglycerol were 
decreased at week 8 for pigs fed excess calcium (P<0.05) or excess 
cholecalciferol (P<0.10). Concentrations of plasma phospholipid decreased 
after week 6 (P<0.10) and continued to decrease at week 8 (P<0.05). 
Concentrations of plasma cholesterol decreased after week 6 (P<0.10) but 
were not different between weeks 7 and 8. Pigs fed excess calcium had 
decreased (P<0.10) plasma cholesterol concentrations at week 8 compared to 
pigs fed the recommended amount of calcium. Concentrations of LDL- and 
HDL-cholesterol did not show significant calcium or cholecalciferol 
effects at the three weeks sampled. Concentrations of HDL-cholesterol 
were less (P<0.01) at weeks 7 and 8 but week 7 was not significantly 
different from week 8, 
Bile flow and composition data are presented in Table 3 and Figure 1. 
Pigs fed excess calcium had less (P<0.01) bile flow and greater (P<0.05) 
concentration of total bile acids in bile than did pigs fed the 
recommended amount of calcium. Concentration of cholesterol and 
phospholipid in bile was not significantly affected by dietary calcium or 
cholecalciferol. Bile flow and biliary lipid content gave the 
corresponding secretion rates of biliary lipid for each diet. Output of 
bile acids and phospholipid were not significantly affected by dietary 
59 
calcium or cholecalciferol. Pigs fed the recommended amount of calcium, 
however, tended to secrete a greater amount of bile acids and phospholipid 
during the 48-hr sampling period than did pigs fed the three-fold amount 
of calcium. Biliary cholesterol output was greater (P<0.05) from pigs fed 
the recommended amount of calcium. Dietary cholecalciferol did not 
significantly affect bile flow rate or the concentration and secretion of 
biliary lipids. Figure 1 presents data on bile flow during the 48-hr 
sampling period. Data points indicate bile flow rate during the time 
interval from the previous sample. Bile flow rate for pigs fed 3XCa diets 
was fairly constant during the sampling period, while pigs fed IXCa diets 
had more variation in bile flow rates. 
TABLE 3. Effects of dietary calcium and cholecalclferol on bile parameters 
Diet^  
Item IXCa IXCa IXCa 3XCa 3XCa 3XCa 
IXD 5XD 25XD IXD 5XD 25XD S EM 
Bile flow^ 70.1 
(mL/hr) 
Concentration 
(mmol/L) 
Bile acids^ 45.2 
Cholesterol 1.3 
Phospholipid 4.6 
Output 
(mmol/48 hr) 
Bile acid 152.1 
Cholesterol 4.4 
Phospholipid 15.5 
67.3 72.0 51.1 
45.5 44.2 52.8 
1.4 1.1 1.0 
6.2 5.9 6.8 
147.0 152.7 129.5 
4.5 3.8 2.5 
20.0 20.3 16.7 
50.3 55.1 3.1 
55.3 48.7 1.6 
1.1 1.4 0.1 
5.3 6.0 0.4 
133.5 128.8 43.8 
2.7 3.7 1.9 
12.8 15.9 6.0 
^IXCa and 3XCa refers to one and three times daily dietary requirement of calcium; IXD, 5XD, 
and 25XD refers to one, five, and 25 times the daily requirement of cholecalclferol. Values are 
means for six pigs per diet. 
^SEM = standard error of the mean. 
"^ Calcium effect (P<0.01) 
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DISCUSSION 
The greatest number of deaths following surgery resulted from blockage 
of the small intestine after adhesion of the small intestine to other 
organs and to the body wall. Adhesions of varying severity were observed 
in all pigs that survived through the surgeries. Hyvarinen et al. (1989) 
found that 25 of 100 cholecystectomized human patients had severe 
adhesions of the duodenum following surgery. Gastric ulcers are not 
uncommon in pigs and were observed in most pigs that completed the current 
study. Moran (1982) listed several factors that increase the incidence 
and severity of gastric ulcers, including finely ground feed ingredients, 
bile reflux, cholestasis, trauma from surgery, high dietary calcium and 
stress from individual penning. Hyvarinen et al. (1989) reported that the 
frequency of active gastric ulcers was significantly increased in 
cholecystectomized patients. Animal care and use regulations of research 
animals prohibited repeated major surgeries to repair failed catheters. 
The 36 pigs that completed the study were assumed to have recovered 
from surgery when they would eat their full allotment of feed between 
consecutive feedings. Table 2 shows that pigs continued to gain weight 
after surgery. Using weight gain as a measure of recovery from surgery, 
pigs fed excess calcium recovered faster than did pigs fed the recommended 
amount of calcium. Concentration of plasma triacylglycerol increased 
after surgery, whereas concentration of plasma phospholipid and 
cholesterol decreased at weeks 7 and 8. Carpentier and Thonnart (1987) 
found significantly decreased concentrations of plasma triacylglycerol and 
cholesterol in human patients following major surgery. Plasma 
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triacylglycerol concentrations in the human patients returned to pre­
operative values by day 4 after surgery, whereas plasma cholesterol 
concentrations remained significantly lower at day 4 after surgery. 
Concentration of cholesterol in LDL did not show significant treatment or 
time differences at the three times measured. Concentration of HDL-
cholesterol did not show treatment differences but decreased from week 6 
compared to weeks 7 and 8 and was unchanged from week 7 to week 8. 
Pigs fed the recommended amount of calcium had a bile flow rate of 
69.8 mL/hr, while pigs fed excess calcium produced 52.2 mL/hr of bile 
during the 48-hr sampling period. Egger et al. (1974) reported bile flow 
of 0.31 to 0.55 mL/min (18.6 to 33 mL/hr) from 37-kg pigs during 10-minute 
sampling periods. Sambrook (1981) reported that pigs weighing 
approximately 37 kg secreted an average of 60 mL bile/hr over two 24-hr 
collection periods. Juste et al. (1979) reported that 47-kg pigs secreted 
2,100 mL over 24 hours (87.5 mL/hr). Juste et al. (1983a) found that 50-
kg pigs secreted an average of 2,570 mL over 24 hr (107 mL/hr) during a 6-
day period of bile collection and re-infusion. Juste et al, (1983b) 
reported average bile secretion of 87 mL/hr from 30-kg pigs during a 6-day 
collection period. The rate of bile flow during the sampling period was 
variable (Figure 1). Sambrook (1981) reported wide and rapid fluctuations 
in bile flow rate of pigs measured during three-minute sampling periods. 
Juste et al. (1983b) reported large fluctuations in bile flow rate of 30-
kg pigs measured during two-hour intervals. 
One method of comparison of bile flow rates across different body 
weights and species is to calculate bile flow per hour per unit of body 
65 
weight. In the current study, pigs secreted 47 mL per 24-hr period per kg 
body weight, which compares with other values reported for pigs: 47 (Juste 
et al., 1979), 51 (Juste et al., 1983a), and 70 (Juste et al., 1983b). 
Values reported for other species include: man, 9 (Miettinen, 1973), dog, 
10 (Wheeler and Ramos, 1960), sheep, 21 (Heath et al., 1970), calves, 43 
(Davis et al., 1985) and 69 (Debarre et al., 1979), and adult steers, 20 
(Symonds and Mallison, 1982). 
Concentration of bile acids in bile was greater for pigs fed excess 
calcium (52.3 mmol/L) than for pigs fed the recommended amount of calcium 
(45.0 mmol/L). Concentrations of bile acids, cholesterol and 
phospholipids in bile are similar to values reported by Juste et al. 
(1983b) for pigs fed diets containing 20% lard. Output of biliary lipids 
was greater for pigs fed the recommended anount of calcium than for pigs 
fed three times the recommended amount of calcium. Dietary 
cholecalciferol did not affect the output of biliary lipids. Values 
reported in Table 3 for secretion of biliary lipids are less than biliary 
secretion values reported by Juste et al. (1983b). Admirand and Small 
(1968) plotted the relative molar concentrations of biliary bile acids, 
cholesterol and phospholipids on triangular coordinates to allow 
prediction of the maximal amount of cholesterol that can be solubilized in 
solutions containing varying proportions of bile acids and phospholipid. 
The authors found that bile composition from normal human patients having 
stable, mixed biliary micelles was plotted in very narrow limits on the 
triangular coordinates. Bile composition from patients with cholesterol 
gallstones was outside the limit for normal micellar formation. Pigs have 
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very low molar percentages of cholesterol relative to molar percentages of 
bile acids and phospholipids in bile and thus do not spontaneously form 
cholesterol gallstones. 
In summary, dietary calcium and cholecalciferol have been evaluated 
as to their effect on bile flow and composition in young pigs. Pigs fed 
excess calcium had less bile flow but greater concentration of biliary 
bile acids than did pigs fed recommended amounts of calcium. 
Concentration of biliary cholesterol and phospholipid were not affected by 
dietary calcium. Dietary cholecalciferol did not affect any of the bile 
parameters measured. 
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SECTION 2. EFFECT OF DIETARY CALCIUM AND CHOLECALCIFEROL ON 
TRANSFER OF LOW DENSITY LIPOPROTEIN-CHOLESTEROL 
INTO BILE AND TISSUES OF YOUNG PIGS 
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ABSTRACT 
Thirty-six crossbred, castrated male pigs with an average initial 
weight of 10.2 kg at six weeks of age were fed diets containing either one 
or three times the daily requirement of calcium and one, five or 25 times 
the requirement of cholecalciferol in a 2 x 3 factorial design. During 
week 6, pigs were fitted with femoral arterial, common bile duct and 
duodenal catheters. After week 8, pigs were injected with autologous low-
density lipoprotein enriched with cholesterol. Serial blood and bile 
samples were collected for 48 hours. Pigs secreted an average of 24.6% of 
injected 'h-cholesterol into bile as bile acids and 5.6% of injected dose 
as biliary cholesterol during the 48-hour period after injection. No 
significant treatment differences were observed, but the percentage of 
injected dose secreted as bile acids and biliary cholesterol tended to be 
greater for pigs fed excess dietary calcium. No significant treatment 
effects were observed on concentrations of lipid in aorta, carcass, liver, 
skeletal muscle, perirenal adipose or viscera samples. Pigs fed excess 
cholecalciferol had less (P<0.05) lipid in heart tissue. An interaction 
between calcium and cholecalciferol was observed (P<0.10) for subcutaneous 
adipose tissue. Pigs fed excess calcium and five-fold cholecalciferol had 
decreased lipid content in subcutaneous adipose tissue when compared to 
pigs fed the recommended amounts of both, but the lipid content increased 
when 25-fold cholecalciferol and excess calcium were fed. The opposite 
effect was seen when excess amounts of cholecalciferol were fed with the 
recommended amount of calcium. Significant treatment effects were not 
seen for concentration of cholesterol in tissues or percentage of injected 
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cholesterol deposited per gram of dry tissue. Aortas sectioned 
lengthwise and stained with Sudan IV to detect lipid deposition showed 
only traces of fatty streaking, but no treatment differences were evident. 
In conclusion, dietary calcium and cholecalciferol did not affect 
cholesterol deposition in tissues or secretion into biliary cholesterol 
and bile acids. 
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INTRODUCTION 
Calcium and vitamin D are integral components of the American diet. 
Numerous epidemiological and nutritional studies have shown that dietary 
calcium and vitamin D can affect the concentration of plasma cholesterol 
and the development of atherosclerosis. Dietary calcium decreased the 
concentration of plasma cholesterol in humans (Bierenbaum et al., 1972), 
rabbits (Yacowitz et al., 1971), rats (Yacowitz et al., 1967) and goats 
(Mines et al., 1985). Dietary calcium has been purported to have a 
protective role in atherosclerosis (Yacowitz et al., 1971; Renaud et al., 
1983). In contrast, calcification is a characteristic of atherosclerotic 
plaques (Moon, 1972). Phair (1988) suggested that intracellular calcium 
is the pathological second messenger of atherogenesis and that diverse 
risk factors for the development of atherosclerosis promote intracellular 
calcium accumulation. 
Vitamin D has been incriminated as a positive risk factor in 
atherosclerosis, but reports on the role of vitamin D in the development 
of hypercholesterolemia are not conclusive. Excess dietary vitamin D has 
been shown to be hypercholesterolemic in humans (Fleischman et al., 1970; 
Curcic and Curcic, 1975), squirrel monkeys (Peng et al., 1978), rats 
(Fleischman et al., 1972) and swine (Huang et al., 1977). In contrast, 
other studies showed that excess dietary vitamin D did not cause 
hypercholesterolemia in humans (Carlson et al., 1970; Vik et al., 1979), 
rats (Jurgens et al., 1971) and goats (Mines et al., 1985). Excess 
vitamin D induced or increased atherosclerotic lesions in rats (Gambal and 
Murphy, 1979), rabbits (Mass et al., 1969), squirrel monkeys (Peng et al., 
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1978) and swine (Huang et al., 1977; Toda et al., 1985). Peng and Taylor 
(1980) suggested that excess consumption of vitamin D may be the most 
significant risk factor in atherogenesis, with other factors being of 
secondary importance. 
The concentration of plasma cholesterol can be decreased by uptake of 
cholesterol by several tissues. Cholesterol taken up by the liver can be 
converted to bile acids for secretion into bile or transferred directly 
into bile as biliary cholesterol. The hypothesis of this study was that 
dietary calcium and cholecalciferol influence the entry rate of 
cholesterol of plasma low-density lipoproteins (LDL) into tissues and into 
bile as bile acids and biliary cholesterol. The specific objectives were 
to determine the effects of amount of dietary calcium and cholecalciferol 
fed to young pigs on (1) concentrations of cholesterol in aorta, heart, 
liver, skeletal muscle and viscera of pigs, (2) uptake of LDL from plasma 
by liver and subsequent transfer of the LDL-cholesterol into bile as 
cholesterol and (3) conversion of LDL-cholesterol to bile acids in liver 
and the secretion of the bile acids into the bile. 
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MATERIALS AND METHODS 
Thirty-six crossbred, castrated male pigs with an average initial 
weight of 10.2 kg at approximately six weeks of age were allotted randomly 
to six dietary treatments (six pigs per treatment). The experimental 
design was a 2 x 3 factorial arrangement with two concentrations of 
calcium and three concentrations of cholecalciferol supplementation to a 
basal diet. Pigs were housed in an environmentally controlled facility in 
individual pens on sawdust-covered floors. Water was available ad libitum 
from automatic nipple waterers. Pigs were weighed weekly, and daily feed 
intake was adjusted to 4.5% of body weight, dry-matter basis. Pigs were 
fed twice daily throughout the 8-week feeding portion and the 48-hour 
sampling portion of the study. 
Dietary ingredients are shown in Table 1. The calcium concentrations 
were one (IXCa) and three (3XCa) times the daily requirement for young 
pigs (NRC, 1979). The cholecalciferol concentrations were (1) one times 
(IXD), (2) five times (5XD) and (3) 25 times (25XD) the daily requirement 
for young pigs (NRC, 1979). Concentrations of calcium and cholecalciferol 
in the IXCa-IXD diet were 0.65% and 0.5 fig, respectively. Diets 
containing the recommended daily amount of calcium (IXCa) also contained a 
fine-mesh, calcium-free silica sand to make each diet isonitrogenous, 
isocaloric and similar in consistency. Cholecalciferol was added to the 
diets as a suspension of crystalline cholecalciferol in a minimal amount 
of soybean oil. Powdered egg yolks were added to the diets as a source of 
cholesterol. The concentration of cholesterol in each diet was calculated 
to be fed at 20 mg/kg body weight (0.046% of diet) daily. Finely ground 
TABLE 1. Ingredient composition of diets 
IXCa IXCa IXCa 3XCa 3XCa 3XCa 
Ingredient ]^ D 5XD 25XD DÇD 5XD 25XD 
Calcium carbonate^ 0.3 0.3 0.3 3.6 3.6 3.6 
(% dry matter) 
Silica sand (100 mesh)® 3.3 3.3 3.3 0 0 0 
(% dry matter) 
Cholecalciferol^ 0.5 2.5 12.5 0.5 2.5 12.5 
(/ig/100 g feed) 
^IXCa and 3XCa refers to one and three times daily dietary requirement of calcium; IXD, 5XD and 
25XD refers to one, five and 25 times the daily requirement of cholecalciferol. Values are means 
for six pigs per diet. 
^All diets contained the following (on a % dry matter basis): ground shelled com, 37.0; dried 
skim milk, 40.5 (donated by United States Department of Agriculture, Agricultural Stabilization and 
Conservation Service, courtesy of R. H. Sindt); soybean oil, 16.4 (donated by Central Soya Co., 
Inc., Fort Wayne, IN, courtesy of D. Strayer); egg yolk, 1.6 (used as a source of cholesterol, 
donated by Henningsen Foods, Inc., Omaha, NE, courtesy of D. H. Bergquist) and vitamin and mineral 
mix, 0.9 (donated by Feed Specialties Co., Des Moines, lA, courtesy of L. Russell. Guaranteed 
analysis (per kg.): 416 g rice hulls, 288 g sodium chloride, 143 g 1-lysine-HCl, 63.0 g choline 
chloride, 45.4 g ferrous sulfate monohydrate, 19.3 g zinc oxide, 10.9 g manganous oxide, 3.80 g 
niacin, 2.88 g riboflavin, 2.05 g d-calcium pantothenate, 2.70 g cupric oxide, 1,50 g menadione 
bisulfite complex, 1.26 g dl-alpha-tocopheryl acetate, 1.15 g cyanocobalamin, 0.85 g retinyl 
acetate, 125 mg biotin, 75 mg ethylenediamine dihydroiodate and 25 mg folic acid). 
^Diets for all animals were supplemented with 3.5g psyllium seed per day, donated by Feed 
Specialties, Des Moines, lA, courtesy of L. Russell. 
F^re-Flo Alden Ground Limestone, Iowa Limestone Co., Des Moines, lA. Guaranteed analysis: 
calcium carbonate, not less than 98.00%; calcium, not more than 39.60% and not less than 39.20%. 
^Donated by 3M, Ames, lA, courtesy of G. Stevens. 
S^igma Chemical Co., St. Louis, MO. 
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psyllium seed was added as a fiber source at 3.5 g per head daily, the 
recommended dosage of Metamucil" for humans by Proctor and Gamble 
(Cincinnati, OH) to prevent constipation. On a dry-matter basis, each 
diet contained 3.98 kcal ME/g, 18.2% protein and 19% fat. 
During week 6, each pig was fitted with a femoral artery catheter, 
bile duct catheter and re-entrant duodenal catheter. All surgeries were 
performed under the guidelines of the American Association of Laboratory 
Animal Care. Anesthesia was induced and maintained with halothane inhaled 
through a mask. The femoral artery catheter was placed such that its tip 
extended into the thoracic aorta. The other end was threaded 
subcutaneously and exteriorized at the ridge of the back behind the 
shoulder. Patency of the catheters was maintained by flushing them every 
other day with a sodium heparin solution (192 lU/ml) in sterile 0.15 N 
NaCl solution. 
After the femoral artery was catheterized, each pig was fitted with 
bile duct and re-entrant duodenal catheters as described in Section I. 
Other pigs weighing approximately 25 kg also were implanted with the bile 
duct and re-entrant duodenal catheters. These pigs were fed treatment 
diets and maintained as bile-donor pigs. Bile from these pigs was 
collected daily and stored at 4°C until needed for re-infusion into test 
pigs. 
During week 5, approximately 240 ml of blood was collected from each 
pig by orbital sinus puncture (Huhn et al., 1969). Plasma was separated 
by centrifugation. Low-density lipoprotein (LDL) was separated from the 
plasma by ultracentrifugation after density adjustment (Havel et al.. 
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1955). Approximately 75 ml of an LDL solution resulted from the 240 ml 
blood. This LDL was labeled with [la,2a(n)-^H] cholesterol, specific 
activity 44.7 Curies/mmol, (Amersham, Arlington Heights, IL) by the method 
of Schwartz et al. (1978a). 
The labeled LDL was injected at the end of the 8-week feeding period 
through the femoral artery catheter into the same pig from which the LDL 
was obtained. Injection was followed immediately with injection of 60 ml 
of blood taken from the same pig just before LDL injection to ensure that 
all of the labeled LDL mixed with circulating blood. 
Serial bile samples were collected at 5, 15, 30 and 45 minutes and at 
1, 2, 4, 8 12, 18, 24, 36 and 48 hours post-injection. A 10-mL aliquot of 
bile was collected and stored at -20°C until analyzed. Between sampling 
times, bile was allowed to flow freely from the bile duct catheter into a 
graduated collecting bottle. At each sampling time, the volume collected 
was recorded, and a 10-mL aliquot was stored at -20°C until analyzed. 
Bile previously collected from bile-donor pigs was pumped into the re­
entrant duodenal catheter at a rate approximately equal to the rate of 
bile flow out of the pig. This allowed each pig to be in a steady-state 
condition with regard to bile acid metabolism. 
A 1-mL aliquot of each bile sample was separated into bile acid and 
cholesterol fractions by extraction with 1:2:0.8 
(cholorofom:methanol:water) as the extraction solvent (Bligh and Dyer, 
1959). Verification of recoveries of bile acids and cholesterol by this 
procedure was performed by adding both [^ H]-cholesterol and [^ C^]-cholic 
acid to non-radioactive bile samples, then extracting each sample and 
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measuring the radioactivity in the aqueous and chloroform phases by using 
standard dual-label liquid scintillation counting techniques. It was 
found that 97% of the [%]-cholesterol was recovered in the chloroform 
phase and 96% of the [^^C] -cholic acid was recovered in the aqueous phase. 
Only trace counts were detected in the aqueous phase, and only trace 
counts were detected in the chloroform phase. 
Pigs were killed 48 hours after injection of labeled LDL by injection 
of 10 mL of a 5% solution of Surital" (thiamylal sodium, Parke-Davis, 
Morris Plains, NJ) to induce anesthesia, followed by exsanguination. 
Tissues collected included aorta, carcass minus brain and spinal cord, 
heart, liver, Longissimus dorsi muscle, perirenal and subcutaneous adipose 
tissues and viscera minus digesta. The aortas were split lengthwise into 
two pieces. One piece was saved for lipid and cholesterol analyses. The 
other piece was fixed for 24 hours in 10% formalin and then stained with 
Sudan IV stain to detect lipid deposition (Holman et al., 1958). All 
tissues were stored at -20°C until analysis. 
Carcass, heart, liver and viscera were ground in a meat grinder. 
Aorta, L. dorsi muscle and perirenal and subcutaneous adipose tissues were 
frozen in liquid nitrogen and pulverized in a Waring blender. A 20-g 
sample of each tissue was lyophilized to determine percentage of dry 
matter. -Total lipid was extracted from 500-mg samples of freeze-dried 
tissue with 1:2:0.8 choloroform:methanol:water as the extraction solvent 
(Bligh and Dyer, 1959). Content of lipid in tissues was determined 
gravimetrically after lipid extracts were evaporated to dryness. 
Concentration of total cholesterol in tissues was determined enzymatically 
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(Sigma Cholesterol kit No. 352, Sigma Chemical Co., St. Louis, MO) on 
aliquots of the total lipid extracts that were evaporated to dryness and 
redissolved in isopropanol. Viscera and muscle samples had interfering 
cloudiness in the assay procedure and required filtering with 0.22 /Ltm 
filters (Millipore, Bedford, MA) before reading the absorbance with the 
spectrophotometer. Total radioactivity of [^H]-cholesterol in the tissues 
was measured by liquid scintillation counting of total lipid extracts that 
were evaporated to dryness and redissolved in scintillation cocktail. 
Data were analyzed by the general linear model (GLM) procedure of SAS 
(1982) for main effects of calcium and cholecalciferol, and for calcium by 
cholecalciferol interaction in a 2 x 3 factorial arrangement of a 
completely randomized design. Data are expressed as group means with 
pooled standard errors of the mean. 
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RESULTS 
The results of the first six weeks of the feeding period have been 
reported by Foley et al. (1990). Briefly, excess dietary calcium 
significantly decreased the body weight gain of pigs. Excess dietary 
calcium increased the phospholipid concentration in the plasma, but not in 
any of the lipoproteins. Calcium variation had no effect on cholesterol, 
triacylglycerol or protein concentrations in plasma and lipoproteins. 
Dietary cholecalciferol variation had no effect on body weight gain or 
concentrations of cholesterol, phospholipid, triacylglycerol or protein in 
plasma and lipoproteins. Increased cholecalciferol intake resulted in 
increased plasma 25-hydroxycholecalciferol, whereas high dietary calcium 
decreased the 1,25-dihydroxycholecalciferol concentrations. Increased 
dietary calcium also increased plasma calcium concentrations. Overall, 
excess dietary calcium depressed growth rate and increased concentrations 
of only plasma phospholipids, whereas excess dietary cholecalciferol had 
no effect on growth or lipid composition of plasma in growing pigs. 
No significant effects of dietary c.-:lcium or cholecalciferol on 
concentration of lipid in aorta, carcass, liver, muscle, perirenal adipose 
or viscera samples were observed (Table 2). Pigs fed excess 
cholecalciferol had less (P<0.05) lipid in their heart tissue. No 
difference in lipid content of heart tissue was observed between pigs fed 
five and twenty-five times the recommended amount of cholecalciferol. An 
interaction (P<0.10) between calcium and cholecalciferol was observed for 
subcutaneous adipose tissue. Pigs fed excess calcium and five-fold 
cholecalciferol had decreased lipid content in subcutaneous adipose tissue 
TABLE 2. Effects of dietary calcium and cholecalciferol on lipid content of tissues 
Diet^  
IXCa IXCa IXCa 3XCa 3XCa 3XCa 
Tissue IXD 5XD 25XD IXD 5XD 25XD 
% of tissue dry matter 
Aorta 16.9 13.3 17.1 21.3 15.3 15.3 1.4 
Carcass 40.9 42.2 46.6 47.3 41.6 46.4 1.1 
Heart^ 19.9 14.2 13.8 22.9 13.8 14.2 1.2 
Liver 11.0 10.5 9.8 10.9 11.0 10.9 0.3 
Muscle 9.3 12.6 9.5 13.5 12.1 12.9 0.8 
Perirenal 
adipose 
87.4 87.4 89.7 88.4 91.8 92.6 0.8 
Subcutaneous 
adipose^  
86.0 90.5 87.7 88.5 86.1 94.5 
* 
1.0 
Viscera 26.3 25.9 33.4 32.0 28.9 35.4 1.5 
I^XCa and 3XCa refers to one and three times daily dietary requirement of calcium; IXD, 5XD 
and 25XD refers to one, five and 25 times the daily requirement of cholecalciferol. Values are 
means for six pigs per diet. 
S^EM - standard error of the mean. 
^Cholecalciferol effect, IXD vs. 5XD and 25XD (P<0.05). 
'^Calcium x chalecalciferol interaction (P<0.10). 
TABLE 3. Effect of dietary calcium and cholecalclferol on cholesterol content of tissues and 
percentage of injected -^cholesterol deposited in tissues 
Diet* 
IXCa IXCa IXCa 3XCa 3XCa 3XCa . 
Tissue IXD 5XD 25XD IXD 5XD 25XD SEM 
Aorta 
cholesterol (mg/g DM) 6.7 4.9 4.6 7.7 5.3 7.6 0.6 
% dose/g DM 0.104 0.054 0.059 0.099 0.093 0.077 0.011 
Heart 
cholesterol (mg/g DM) 6.8 7.3 6.4 7.3 7.0 6.6 0.2 
% dose/g DM 0.051 0.069 0.051 0.085 0.070 0.056 0.007 
Liver 
cholesterol (mg/g DM) 5.5 7.2 8.5 5.7 7.4 6.9 0.6 
% dose/g DM 0.080 0.087 0.070 0.104 0.106 0.066 0.008 
Muscle 
cholesterol (mg/g DM) 5.2 4.8 8.8 5.1 3.9 5.5 1.0 
% dose/g DM 0.053 0.056 0.027 0.083 0.049 0.074 0.010 
Viscera 
cholesterol (mg/g DM) 6.4 6.0 6.5 6.0 5.5 5.6 .4 
% dose/g DM 0.008 0.012 0.011 0.014 0.015 0.009 0.002 
*lXCa and 3XCa refers to one and three times daily dietary requirement of calcium; IXD, 5XD and 
25XD refers to one, five and 25 times the daily requirement of cholecalclferol. Values are means 
for six pigs per diet. 
^SEM - standard error of the mean. 
TABLE 4. Effects of dietary calcium and cholecalclferol on bile acids and biliary cholesterol 
• Diet* 
Bile IXCa IXCa IXCa 3XCa 3XCa 3XCa 
Constituent IXD 5XD 25XD IXD 5XD 25XD SEM^ 
Bile acid": 26.1 22.1 20.2 25.6 28.3 25.3 1.3 
Cholesterol*^  4.6 5.5 5.2 5.1 6.1 7.2 0.3 
*lXCa and 3XCa refers to one and three times daily dietary requirement of calcium; IXD, 5XD, 
and 25XD refers to one, five, and 25 times the daily requirement of cholecalclferol. Values are S 
means for six pigs per diet. 
S^EM — standard error of the mean. 
'^ Percentage of injected cholesterol secreted into bile as bile acids during 48 hours after 
injection. 
'^Percentage of injected cholesterol secreted into bile as cholesterol during 48 hours after 
injection. 
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when compared to pigs fed the recommended amounts of both, but the lipid 
content increased when 25-fold cholecalciferol and excess calcium were 
fed. The opposite effect was seen when excess amounts of cholecalciferol 
were fed with the recommended amount of calcium. 
Data for the effect of dietary calcium and cholecalciferol on 
concentration of cholesterol in selected tissues and the percentage of 
injected cholesterol deposited per gram of dry tissue are presented in 
Table 3. No significant treatment effects were observed for cholesterol 
concentration or deposition in any of the tissues measured. 
No significant treatment effects were observed for percentage of 
injected dose of H^-cholesterol secreted in bile as bile acids or biliary 
cholesterol (Table 4). Pigs fed high calcium diets, however, tended to 
secrete a greater percentage of injected dose as biliary bile acids and 
cholesterol. 
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DISCUSSION 
Dietary calcium did not significantly affect concentration of 
cholesterol or total lipids in tissues measured. Pigs fed excess 
cholecalciferol showed a decrease in lipid concentration in heart tissue, 
but no difference in lipid content of heart tissue was observed between 
the two excess amounts of dietary cholecalciferol. Concentration of 
cholesterol and total lipid in other tissues was not significantly 
affected by dietary cholecalciferol. In addition, the percentage of 
injected ^ H-cholesterol deposited per gram of dry tissue was not 
significantly affected by dietary calcium or cholecalciferol. Diersen-
Schade et al. (1984) reported that supplementation of dietary calcium to 
young goats increased cholesterol and lipid concentrations of livers but 
did not affectthe concentrations in viscera minus liver or carcass. An 
effect of dietary calcium on aortic lipid deposition was not observed. 
Mines et al. (1985) observed no dietary calcium or cholecalciferol effects 
on total lipid or cholesterol concentrations in liver, other viscera, 
carcass or whole body of young goats. Studies in rats (Fleischman et al., 
1967) and rabbits (lacono, 1974; Dougherty and lacono, 1979) have shown 
dietary calcium to decrease cholesterol concentration in liver. 
Supplemental cholecalciferol increased concentrations of cholesterol in 
liver of rats (Lee and Herrmann, 1957; Jurgens et al., 1971) and swine 
(Jurgens and Peo, 1970). Total lipids in liver, however, were unaffected 
by dietary calcium (Fleischman et al., 1967; Yacowitz et al., 1967) and 
vitamin D (Dalderup, 1965; Huang et al., 1977). Inconsistent effects of 
dietary calcium and vitamin D on lipid and cholesterol deposition in other 
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tissues have been reported (Fleischman et al., 1967; Yacowitz et al., 
1967; Dougherty and lacono, 1979). 
One-half of the length of each aorta was stained with Sudan IV dye. 
None of the aortas showed the characteristic reddish color of stained 
fatty streaks. In addition, none of the aortas exhibited the rougher 
texture observed by Hines et al. (1985) in young goats fed excess 
cholecalciferol. Damage to the endothelium and subsequent lesion 
formation, however, was observed in the area where the catheter tip was 
situated. Hines et al. (1985) observed only minimal staining in aortas 
from young goats fed excess cholecalciferol. In contrast, Diersen-Schade 
et al. (1984) reported a more apparent sudanophilia in the aortas of milk-
fed goats. These goats, however, were fed supplemental cholesterol and 
dietary fat, which may account for increased lipid deposition in aortic 
tissue. 
Kamio et al. (1977) fed weanling pigs either a basal corn-soybean meal 
ration or a high-fat, high-cholesterol ration. In addition, one subgroup 
of each ration received 220,000 lU cholecalciferol per kg of ration. 
Excess cholecalciferol-supplemented pigs had lesions in the distal 
abdominal aorta after three months of feeding. The lesions consisted of 
diffuse intimai thickening. In all groups, stainable lipids were a minor 
feature and seen as particles in the intima and inner media. Kummerow 
(1979) reported on a study in which raised lesions were found in the 
thoracic aorta of weanling pigs fed 55,000 lU cholecalciferol per kg of 
ration for one month. Some pigs, however, showed no lesions after three 
months of feeding. Electron microscopy of grossly normal areas of the 
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aortas from these pigs indicated a higher frequency of degenerated smooth 
muscle cells when compared with micrographs from pigs fed a basal diet. 
Kummerow (1979) also reported that sections of thoracic aorta from 
weanling pigs fed 27,500 lU cholecalciferol per kg ration for three months 
contained a lipid-free intimai thickening. Pigs fed for six months, 
however, developed extensive lipid deposits and coronary occlusions. 
Thus, similar development of fatty streaks may have occurred in our pigs 
if they had been fed for a longer period of time. 
Dietary calcium and cholecalciferol did not significantly affect the 
percentage of injected ^ H-cholesterol that was secreted as biliary 
cholesterol and bile acids. Pigs secreted an average of 24.6% of injected 
dose into bile as bile acids and 5.6% of injected dose as biliary 
cholesterol during the 48-hr collection period. The percentage of 
injected dose secreted as bile acids and biliary cholesterol tended to be 
greater for pigs fed 3 times the recommended amount of dietary calcium. 
For comparison, Luhman et al. (1989) reported that pigs fed tallow, soy 
oil or a blend of these fats as either 20 or 40% of calories in the diet 
secreted 16.2% of an injected dose of H^-cholesterol in LDL as bile acids 
and 4.5% of the injected dose as biliary cholesterol during a 24-hr 
collection period. 
Recent studies have shown definitive hepatic precursor sites 
associated with the secretion of biliary cholesterol and the synthesis of 
bile acids. Schwartz et al. (1978b) showed that approximately 70% of the 
cholesterol entering the precursor sites was derived from free cholesterol 
associated with lipoproteins, while most of the remaining 30% came 
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directly from newly synthesized hepatic cholesterol. Although no dietary 
treatment differences were seen in the current study, dietary calcium and 
cholecalciferol may have their effect on hypercholesterolemia, and thus 
atherosclerosis, described mechanistically by alterations in secretion of 
bile acids and biliary cholesterol. More research is needed to elucidate 
these mechanisms. 
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GENERAL SUMMARY 
This dissertation reports the results of the second phase of a study 
designed to evaluate the influence of dietary calcium and cholecalciferol 
on (1) concentrations of protein, cholesterol, triacylglycerol and 
phospholipids in plasma, VLDL, LDL and HDL, (2) concentration of 
cholesterol and total lipids in selected tissues, (3) deposition of ^ H-
cholesterol-LDL in selected tissues and (4) uptake of labeled LDL from 
plasma by liver and subsequent transfer of cholesterol into bile as 
bile acids and biliary cholesterol. 
In the first phase, Foley (1988) and Foley et al. (1990) showed that 
excess dietary calcium depressed growth rate and increased concentrations 
of only plasma phospholipids, whereas excess dietary cholecalciferol had 
no effect on growth or lipid composition of plasma in growing pigs. Phase 
2 results showed that pigs fed excess calcium had significantly less bile 
flow, but significantly greater concentration of biliary bile acids, than 
did pigs fed recommended amounts of calcium. Concentration of biliary 
cholesterol and phospholipids were not affected by dietary calcium. 
Dietary cholecalciferol did not affect the bile flow rate or concentration 
of biliary lipids. Dietary calcium and cholecalciferol did not 
significantly affect the percentage of injected %-cholesterol that was 
secreted as biliary cholesterol and bile acids. 
The only significant responses observed for concentration of total 
lipid or cholesterol in tissues were decreased lipid in heart tissue of 
pigs fed excess cholecalciferol and an interaction between calcium and 
cholecalciferol for lipid concentration in subcutaneous adipose tissue. 
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Aortas sectioned lengthwise and stained for lipid deposition showed only 
traces of fatty streaking, with no apparent treatment differences. 
Numerous other studies have been cited in the Review of Literature 
that showed effects of dietary calcium and cholecalciferol on 
concentration of plasma cholesterol, tissue lipids and cholesterol, and 
lipid deposition in arteries. Three suggestions could be made for future 
studies. First, one could use greater amounts of dietary calcium and 
vitamin D as others have done. This may produce significant responses but 
probably would not reflect human intakes of these compounds. Second, 
commonly consumed amounts of calcium and vitamin D could be fed to more 
pigs for a longer period of time. Because pigs grow rapidly and may be 
unmanageable as research animals at a mature size, another animal model 
may need to be used. Turley et al. (1983) discussed the advantages of the 
hamster over the rat for studies involving cholesterol conversion into 
biliary components. The third suggestion would be to use other analytical 
techniques. Schwartz et al. (1978) reported the use of the Simulation 
Analysis and Modeling (SAAM) computer program to analyze the kinetics of 
cholesterol movement between body pools, with special emphasis on the 
transfer of plasma cholesterol into biliary cholesterol and bile acids. 
Staining techniques to identify early atherogenesis by allowing 
visualization of monocyte recruitment into lesion-prone areas of aortas 
have been reported (Gerrity et al., 1985; Bylock and Gerrlty, 1988). A 
more sensitive staining technique may allow the detection of lesion-prone 
areas in arteries of animals fed commonly consumed amounts of calcium and 
cholecalciferol, 
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APPENDIX 
Biliary Surgical Procedure 
Two 30-cm lengths of Silastic" tubing (Dow Corning Medical Products, 
Midland, MI) 2.64 nun (inner diameter) by 4.88 mm (outer diameter) were 
used to prepare the bile duct cannula and the re-entrant duodenal cannula 
A 0.7 cm ribbed piece was cut from a 0.32 cm plastic Y-connector (Nalge 
Co., Rochester, NY), The tubing was swelled with xylenes, and the ribbed 
piece was inserted 1 cm in from one end to form the bile cannula. The re 
entrant cannula was prepared by wrapping a 3.5 cm piece of polyvinyl film 
2 cm in width around the end of the cannula such that 1.5 cm of the wrap 
overlapped the tubing, leaving 2 cm to provide a Bunsen-valve effect at 
the end, thus allowing bile to flow readily into the duodenum but 
preventing backflow of intestinal contents into the catheter during 
peristalsis. The wrap was secured to the cannula using monofilament line 
and a fish-lure knot which covered the ends of the monofilament line. A 
circular piece of flat polyvinyl alcohol sponge 2 mm thick and 2.5 cm in 
diameter with a 0.3 cm hole in the center was prepared as an anchor for 
the re-entrant duodenal cannula. A 0.8 cm cut was made around the 
perimeter of the sponge parallel to the flat surfaces. A 15-cm length of 
0 silk was fitted into the cut and tied loosely. 
All surgeries were performed under the guidelines of the American 
Association of Laboratory Animal Care. After an 18-hr fast, pigs were 
anesthetized with 8 to 10% vaporized halothane administered through an 
inhalant mask. The surgical site was shaved, scrubbed and disinfected. 
The pig was transferred to the operating table and placed in dorsal 
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recumbancy. Anesthesia was maintained with 2% vaporized halothane and 
1000 mL/min oxygen. Lactated Ringer's solution with 5% glucose was 
infused continuously into a previously implanted femoral artery catheter 
at a flow rate of 4 mL/min. 
An 10-cm mid-line incision was made from just caudal to the xyphold 
process to the umbilicus. After retraction of the stomach and small 
intestine, the biliary system was located. The cystic duct was partly 
isolated by blunt dissection and ligated with 0 silk at its junction with 
the common bile duct. To drain the gall bladder, a 20-gauge needle on a 
30-mL syringe was inserted into the apex. Blunt dissection was used to 
isolate the common bile duct from connective tissue. The common bile duct 
was ligated at the duodenum leaving the ends of the ligature loose for 
later use. Another length of silk was placed around the common bile duct 
near the cystic duct for later use in securing the cannula. A 0,5-cm cut 
was made across the common bile duct equidistant from the duodenum and the 
junction of the common bile duct with the cystic duct. The cannula was 
inserted through the opening until the tip was past the cystic duct and 
into the hepatic duct. The cannula was secured with the silk previously 
inserted around the common bile duct, taking care to tie behind the "ribs" 
of the cannula. To maintain alignment of the cannula with the common bile 
duct, the ends of the ligature at the duodenal end were used to secure the 
cannula to the common bile duct at the duodenum. Bile was allowed to flow 
freely from the cannula during the remainder of the surgery. 
After placement of the bile duct cannula, a purse-string suture 1 cm 
in diameter was made in the duodenum opposite the sphinctor of Oddi, A 
121 
0.5-cm cut was made in the center of the purse-string suture into the 
lumen of the duodenum. The cannula was inserted until the valve end was 5 
cm distal to the point of entry. The purse-string was drawn tight and 
tied around the cannula, leaving the ends of the ligature loose. The 
circular piece of polyvinyl alcohol sponge was placed over the cannula, 
passed down to the duodenum and secured to the cannula with 0 silk 
previously tied to the sponge, being careful not to collapse the cannula. 
The ends of the purse-string silk then were tied around the sponge. The 
sponge was sutured to the serosa of the duodenum at three points around 
the edge of the sponge. The cannula was flushed twice with sterile 0.15 N 
NaCl solution to insure straightening of the polyvinyl film at the tip. 
Both cannulas were exteriorized through separate stab wounds in the 
right body wall 10 cm dorsal to the incision. To decrease the incidence 
of infection, the stab wounds were initiated 5 cm dorsal to the incision 
and the cannulas were run subcutaneously before exiting through the skin. 
Sufficient lengths of cannula were looped in the body cavity to prevent 
kinking of the tubing. The exteriorized ends of the cannulas were 
connected with a plastic Y-connector in which one arm of the Y was capped 
with an injection cap. Two antibiotic tablets (tetracycline 
hydrochloride) were inserted into the cavity. The wound was closed in 
three layers, peritoneum, muscle layers and skin. Pocket-type bandages 
were glued over the exteriorized cannulas and further secured with 
elastic, adhesive tape to allow easy access to the cannulas for flushing 
and sampling. 
After surgery, pigs were allowed to regain consciousness, returned to 
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their pens and given one-third of their normal feed allowance. 
Thereafter, feed allowance was increased or decreased according to 
appetite. Antibiotic (penicillin-dihydrostreptomycin) was administered 
intramuscularly each day for three days following surgery. Bile cannulas 
were checked daily for bile flow rates for three days following surgery 
and every other day thereafter. Cannulas were checked by gently clamping 
the bile duct cannula, injecting a small air bubble through the injection 
cap into the re-entrant cannula, releasing the clamp and observing the 
rate of movement of the air bubble. Instead of an air bubble, 5 mL of 
sterile 0.15 N NaCl solution could be injected into the re-entrant cannula 
to flush it. The clamp also could be placed on the re-entrant cannula and 
bile drawn out of the bile duct cannula to clear the cannula of biliary 
sludge. 
Biliary complications in practice surgeries were the result of 
attempts to place both cannulas in the common bile duct. In most of the 
pigs the common bile duct was not large enough to accept both cannulas and 
remain intact. Moving the re-entrant cannula to the duodenum corrected 
this problem. 
These procedures have been used for two studies involving effects of 
dietary components on bile flow and composition. Pigs with biliary 
cannulas were maintained for two weeks, then bile samples were collected 
for 24 to 48 hr in the two studies. In addition, other pigs had bile duct 
and re-entrant duodenal cannulas implanted for the collection of bile to 
be used as replacement bile in the two studies. One of these donor pigs 
was used for bile collection for approximately six months. 
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Equipment List for Surgeries 
The following list includes the instrument pack and the linen pack 
that needs to be sterilized by autoclave. 
Instrument pack 
1-Balfor retractor (4 pieces) 
1-Scalpel handle #4 
1-Scalpel handle #7 
6-Towel clamps 
2-Hemostats, small, curved 
2-Hemostats, large, 90° 
2-Clamp, smooth, tubing 
2-Catheter guides, 1 clamp type, 1 thumb forcep type 
2-Needle nose thumb forceps, 1 long, 1 short 
3-Probes, blunt; 1 short, 1 long, 1 fat 
1-Tissue forcep, rat-tooth, short 
2-Tissue forceps, Russian, 1 long, 1 short 
1-Bulldog clamp 
1-Needle, tapered, non-cutting, small 
1-Muscle spreader 
1-Glass snare 
2-Exteriorizing needles, 1 small, 1 large diameter 
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Linen pack 
1-Drape, large, blue 
5-Drapes, small towel 
5-Wash cloths 
4-Hand towels 
2-Surgical gowns 
2-Polyvinyl alcohol sponges with suture material, in 0.15 N NaCl solution 
2-Gauze packs 
1-Gibco bottle with 200 mL of 0.15 N NaCl solution 
Following is a list of instruments and equipment that need to be 
placed in a cold soak of zephiran and rust inhibitor at least four hours 
prior to surgery. 
1-Scissors, blunt dissecting 
1-Scissor, surgical, straight 
1-Scissor, iris 
1-Scissor, suture 
3-Needle holders, 2 large, 1 small 
1-Femoral artery catheter 
1-Bile duct catheter 
1-Duodenal catheter 
1-Plastic Y-connector with injection cap 
Following is a list of items that will be used during and after 
surgery but do not need to be sterilized. 
1-Steri-drape 
1-Scalpel blade #12 
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1-Scalpel blade #22 
1-Suture material, 0 silk with needle 
1-Suture material, 0 silk without needle 
1-Clip of surgical staples, 10 staples needed per surgery 
2-Glove packs 
2-Masks 
2-Antibiotic tablets (tetracycline hydrochloride) 
1-Bottle Furacin" antibiotic powder 
1-Syringe, 30 mL, unopened 
1-20x1.5 needle, unopened 
1-Syringe, 6 mL, unopened 
4-Gauze in tincture of zephiran 
1-IV pole 
1-Rainin pump + roller tubing 
1-IV administration kit 
1-Lactated Ringer's + 5% glucose, 500 mL bag 
3-Tubing adaptors, 15 gauge (orange) 
1-Stainless steel double-male union 
1-Iodine swab 
2-Pocket-type bandages, 1 femoral, 1 bile duct 
1-Tube branding cement 
1-Tongue depressor 
1-Tape scissors 
1-Roll Coban" wrap 
1-Roll Elasticon* tape, 2" 
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1-Syringe, 6 mL + 18x1 needle 
1-Bottle Combiotic (penicillin-dihydrostreptomycln) 
1-Bag heparinized 0.15 N NaCl solution 
Heparinized 0.15 N NaCl solution (192 lU/mL) was prepared by 
dissolving one million lU sodium heparin (Sigma Chemical Co., St. Louis, 
MO) in 200 mL sterile 0.15 N NaCl solution. The resulting solution was 
pipetted into 10-mL freeze dryer bottles which were capped with injection 
caps and autoclaved 30 min. Add one 10-mL bottle sodium heparin to one 
250 mL bag of 0.15 N NaCl solution to make the 192 lU/mL flushing 
solution. 
